{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T02:15:14Z","timestamp":1791512114131,"version":"4.3.4"},"reference-count":258,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004285","name":"Saint-Petersburg State University","doi-asserted-by":"crossref","award":["95444211 and 129659216"],"award-info":[{"award-number":["95444211 and 129659216"]}],"id":[{"id":"10.13039\/501100004285","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Toffler Foundation"},{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"crossref","award":["19-75-30008-P"],"award-info":[{"award-number":["19-75-30008-P"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH\/NIGMS","award":["(2 SO6 GM08016-39)"],"award-info":[{"award-number":["(2 SO6 GM08016-39)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s11064-025-04525-5","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T09:34:43Z","timestamp":1755768883000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Role of Glial Trace Amine Associated Receptor 1 (TAAR1) and Microbiota in Schizophrenia"],"prefix":"10.1007","volume":"50","author":[{"given":"Vassiliy","family":"Tsytsarev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia N.","family":"Vaganova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Volnova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoia","family":"Fesenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruk","family":"Getachew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul R.","family":"Gainetdinov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousef","family":"Tizabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,21]]},"reference":[{"key":"4525_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-017-0071-9","author":"JP Kesby","year":"2018","unstructured":"Kesby JP, Eyles DW, McGrath JJ, Scott JG (2018) Dopamine, psychosis and schizophrenia: the widening gap between basic and clinical neuroscience. Transl Psychiatry. https:\/\/doi.org\/10.1038\/s41398-017-0071-9","journal-title":"Transl Psychiatry"},{"key":"4525_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/neuro.09.017.2009","author":"VD Calhoun","year":"2009","unstructured":"Calhoun VD, Eichele T, Pearlson G (2009) Functional brain networks in schizophrenia: A review. Front Hum Neurosci. https:\/\/doi.org\/10.3389\/neuro.09.017.2009","journal-title":"Front Hum Neurosci"},{"key":"4525_CR3","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S0165-0173(99)00056-9","volume":"31","author":"G Tononi","year":"2000","unstructured":"Tononi G, Edelman GM (2000) Schizophrenia and the mechanisms of conscious integration. Brain Res Brain Res Rev 31:391\u2013400","journal-title":"Brain Res Brain Res Rev"},{"key":"4525_CR4","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852924000518","author":"MA Cummings","year":"2024","unstructured":"Cummings MA, Arias ALW, Stahl SM (2024) What is the neurobiology of schizophrenia? CNS Spectr. https:\/\/doi.org\/10.1017\/S1092852924000518","journal-title":"CNS Spectr"},{"key":"4525_CR5","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.11177","author":"A Kaur","year":"2020","unstructured":"Kaur A, Basavanagowda DM, Rathod B et al (2020) Structural and functional alterations of the temporal lobe in schizophrenia: a literature review. Cureus. https:\/\/doi.org\/10.7759\/cureus.11177","journal-title":"Cureus"},{"key":"4525_CR6","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/MP.2017.170","volume":"23","author":"S Kelly","year":"2018","unstructured":"Kelly S, Jahanshad N, Zalesky A et al (2018) Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA schizophrenia DTI working group. Mol Psychiatry 23:1261\u20131269. https:\/\/doi.org\/10.1038\/MP.2017.170","journal-title":"Mol Psychiatry"},{"key":"4525_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-83873-y","volume":"11","author":"M Ragu\u017e","year":"2021","unstructured":"Ragu\u017e M, Predrijevac N, Dlaka D et al (2021) Structural changes in brains of patients with disorders of consciousness treated with deep brain stimulation. Sci Rep 11:1\u201311. https:\/\/doi.org\/10.1038\/s41598-021-83873-y","journal-title":"Sci Rep"},{"key":"4525_CR8","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/NRN.2016.57","volume":"17","author":"AA Grace","year":"2016","unstructured":"Grace AA (2016) Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression. Nat Rev Neurosci 17:524\u2013532. https:\/\/doi.org\/10.1038\/NRN.2016.57","journal-title":"Nat Rev Neurosci"},{"key":"4525_CR9","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/BIOM15010010","volume":"15","author":"NS Rawani","year":"2024","unstructured":"Rawani NS, Chan AW, Todd KG et al (2024) The role of neuroglia in the development and progression of schizophrenia. Biomolecules 15:10. https:\/\/doi.org\/10.3390\/BIOM15010010","journal-title":"Biomolecules"},{"key":"4525_CR10","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4103\/0019-5545.58907","volume":"52","author":"VK Yeragani","year":"2010","unstructured":"Yeragani VK, Tancer M, Chokka P, Baker GB (2010) Arvid carlsson, and the story of dopamine. Indian J Psychiatry 52:87. https:\/\/doi.org\/10.4103\/0019-5545.58907","journal-title":"Indian J Psychiatry"},{"key":"4525_CR11","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/J.STEM.2017.06.012","volume":"21","author":"MS Windrem","year":"2017","unstructured":"Windrem MS, Osipovitch M, Liu Z et al (2017) Human iPSC glial mouse chimeras reveal glial contributions to schizophrenia. Cell Stem Cell 21:195-208.e6. https:\/\/doi.org\/10.1016\/J.STEM.2017.06.012","journal-title":"Cell Stem Cell"},{"key":"4525_CR12","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/MP.2016.90","volume":"21","author":"MO Tr\u00e9panier","year":"2016","unstructured":"Tr\u00e9panier MO, Hopperton KE, Mizrahi R et al (2016) Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review. Mol Psychiatry 21:1009\u20131026. https:\/\/doi.org\/10.1038\/MP.2016.90","journal-title":"Mol Psychiatry"},{"key":"4525_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/TP.2017.4","author":"CFMG Van Kesteren","year":"2017","unstructured":"Van Kesteren CFMG, Gremmels H, De Witte LD et al (2017) Immune involvement in the pathogenesis of schizophrenia: a meta-analysis on postmortem brain studies. Transl Psychiatry. https:\/\/doi.org\/10.1038\/TP.2017.4","journal-title":"Transl Psychiatry"},{"key":"4525_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/BF03033907","author":"Y Tizabi","year":"2007","unstructured":"Tizabi Y (2007) Nicotine and nicotinic system in hypoglutamatergic models of schizophrenia. Neurotox Res. https:\/\/doi.org\/10.1007\/BF03033907","journal-title":"Neurotox Res"},{"key":"4525_CR15","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1124\/PR.117.015305","volume":"70","author":"RR Gainetdinov","year":"2018","unstructured":"Gainetdinov RR, Hoener MC, Berry MD (2018) Trace amines and their receptors. Pharmacol Rev 70:549\u2013620. https:\/\/doi.org\/10.1124\/PR.117.015305","journal-title":"Pharmacol Rev"},{"key":"4525_CR16","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/J.STEM.2017.06.012\/ATTACHMENT\/EE6583B6-E8D9-42B4-B279-4F1427C4F626\/MMC2.PDF","volume":"21","author":"MS Windrem","year":"2017","unstructured":"Windrem MS, Osipovitch M, Liu Z et al (2017) Human iPSC glial mouse chimeras reveal glial contributions to schizophrenia. Cell Stem Cell 21:195-208.e6. https:\/\/doi.org\/10.1016\/J.STEM.2017.06.012\/ATTACHMENT\/EE6583B6-E8D9-42B4-B279-4F1427C4F626\/MMC2.PDF","journal-title":"Cell Stem Cell"},{"key":"4525_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/FNCEL.2024.1358450","author":"D Laricchiuta","year":"2024","unstructured":"Laricchiuta D, Papi M, Decandia D et al (2024) The role of glial cells in mental illness: a systematic review on astroglia and microglia as potential players in schizophrenia and its cognitive and emotional aspects. Front Cell Neurosci. https:\/\/doi.org\/10.3389\/FNCEL.2024.1358450","journal-title":"Front Cell Neurosci"},{"key":"4525_CR18","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s10571-019-00772-7","volume":"40","author":"KB Gwilt","year":"2019","unstructured":"Gwilt KB, Gonzalez DP, Olliffe N et al (2019) Actions of trace amines in the brain-gut-microbiome axis via trace amine-associated receptor-1 (TAAR1). Cell Mol Neurobiol 40:191\u2013201","journal-title":"Cell Mol Neurobiol"},{"key":"4525_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/FPHAR.2018.00683","author":"LM Fleischer","year":"2018","unstructured":"Fleischer LM, Somaiya RD, Miller GM (2018) Review and meta-analyses of TAAR1 expression in the immune system and cancers. Front Pharmacol. https:\/\/doi.org\/10.3389\/FPHAR.2018.00683","journal-title":"Front Pharmacol"},{"issue":"12","key":"4525_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41398-022-01860-x","volume":"121","author":"B Wang","year":"2022","unstructured":"Wang B, Zartaloudi E, Linden JF (2022) Bramon E (2022) Neurophysiology in psychosis: the quest for disease biomarkers. Transl Psychiatry 121(12):1\u201310. https:\/\/doi.org\/10.1038\/s41398-022-01860-x","journal-title":"Transl Psychiatry"},{"key":"4525_CR21","doi-asserted-by":"publisher","first-page":"429","DOI":"10.5455\/BCP.20161123044657","volume":"26","author":"F Aricioglu","year":"2016","unstructured":"Aricioglu F, Ozkartal CS, Unal G et al (2016) Neuroinflammation in schizophrenia: a critical review and the future. Klin Psikofarmakol Bul 26:429\u2013437. https:\/\/doi.org\/10.5455\/BCP.20161123044657","journal-title":"Klin Psikofarmakol Bul"},{"key":"4525_CR22","doi-asserted-by":"publisher","first-page":"880568","DOI":"10.3389\/FPSYT.2022.880568\/PDF","volume":"13","author":"EA Ermakov","year":"2022","unstructured":"Ermakov EA, Melamud MM, Buneva VN, Ivanova SA (2022) Immune system abnormalities in schizophrenia: an integrative view and translational perspectives. Front Psychiatry 13:880568. https:\/\/doi.org\/10.3389\/FPSYT.2022.880568\/PDF","journal-title":"Front Psychiatry"},{"key":"4525_CR23","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/ANNUREV-IMMUNOL-051116-052358","volume":"35","author":"M Colonna","year":"2017","unstructured":"Colonna M, Butovsky O (2017) Microglia function in the central nervous system during health and neurodegeneration. Annu Rev Immunol 35:441\u2013468. https:\/\/doi.org\/10.1146\/ANNUREV-IMMUNOL-051116-052358","journal-title":"Annu Rev Immunol"},{"key":"4525_CR24","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/627325","author":"K Ji","year":"2013","unstructured":"Ji K, Miyauchi J, Tsirka SE (2013) Microglia: An active player in the regulation of synaptic activity. Neural Plast. https:\/\/doi.org\/10.1155\/2013\/627325","journal-title":"Neural Plast"},{"key":"4525_CR25","doi-asserted-by":"publisher","first-page":"1356975","DOI":"10.3389\/FPSYT.2024.1356975","volume":"15","author":"C Chaves","year":"2024","unstructured":"Chaves C, Dursun SM, Tusconi M, Hallak JEC (2024) Neuroinflammation and schizophrenia \u2013 is there a link? Front Psychiatry 15:1356975. https:\/\/doi.org\/10.3389\/FPSYT.2024.1356975","journal-title":"Front Psychiatry"},{"key":"4525_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2022.114812","author":"WW Eaton","year":"2022","unstructured":"Eaton WW, Rodriguez KM, Thomas MA et al (2022) Immunologic profiling in schizophrenia and rheumatoid arthritis. Psychiatry Res. https:\/\/doi.org\/10.1016\/j.psychres.2022.114812","journal-title":"Psychiatry Res"},{"key":"4525_CR27","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.biopsych.2013.12.002","volume":"75","author":"RR Girgis","year":"2014","unstructured":"Girgis RR, Kumar SS, Brown AS (2014) The cytokine model of schizophrenia: emerging therapeutic strategies. Biol Psychiatry 75:292\u2013299. https:\/\/doi.org\/10.1016\/j.biopsych.2013.12.002","journal-title":"Biol Psychiatry"},{"key":"4525_CR28","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/S41398-022-02115-5","volume":"12","author":"S Knight","year":"2022","unstructured":"Knight S, McCutcheon R, Dwir D et al (2022) Hippocampal circuit dysfunction in psychosis. Transl Psychiatry 12:344. https:\/\/doi.org\/10.1038\/S41398-022-02115-5","journal-title":"Transl Psychiatry"},{"key":"4525_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2017.00027","author":"A Ledonne","year":"2017","unstructured":"Ledonne A, Mercuri NB (2017) Current concepts on the physiopathological relevance of dopaminergic receptors. Front Cell Neurosci. https:\/\/doi.org\/10.3389\/fncel.2017.00027","journal-title":"Front Cell Neurosci"},{"key":"4525_CR30","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/S41583-023-00702-Z","volume":"24","author":"L Cheadle","year":"2023","unstructured":"Cheadle L (2023) Neuron\u2013glia communication through bona fide synapses. Nat Rev Neurosci 24:395. https:\/\/doi.org\/10.1038\/S41583-023-00702-Z","journal-title":"Nat Rev Neurosci"},{"key":"4525_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/FNCEL.2022.929529","author":"E Mata-Mart\u00ednez","year":"2022","unstructured":"Mata-Mart\u00ednez E, D\u00edaz-Mu\u00f1oz M, V\u00e1zquez-Cuevas FG (2022) Glial cells and brain diseases: inflammasomes as relevant pathological entities. Front Cell Neurosci. https:\/\/doi.org\/10.3389\/FNCEL.2022.929529","journal-title":"Front Cell Neurosci"},{"key":"4525_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/FPHYS.2021.740939","author":"RG Mira","year":"2021","unstructured":"Mira RG, Lira M, Cerpa W (2021) Traumatic brain injury: mechanisms of glial response. Front Physiol. https:\/\/doi.org\/10.3389\/FPHYS.2021.740939","journal-title":"Front Physiol"},{"key":"4525_CR33","doi-asserted-by":"publisher","first-page":"6577","DOI":"10.1007\/S12035-021-02574-9","volume":"58","author":"A Quincozes-Santos","year":"2021","unstructured":"Quincozes-Santos A, Santos CL, de Souza Almeida RR et al (2021) Gliotoxicity and glioprotection: the dual role of glial cells. Mol Neurobiol 58:6577\u20136592. https:\/\/doi.org\/10.1007\/S12035-021-02574-9","journal-title":"Mol Neurobiol"},{"key":"4525_CR34","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/S2215-0366(19)30302-5","volume":"7","author":"AG Dietz","year":"2019","unstructured":"Dietz AG, Goldman SA, Nedergaard M (2019) Glial cells in schizophrenia: a unified hypothesis. Lancet Psychiatry 7:272. https:\/\/doi.org\/10.1016\/S2215-0366(19)30302-5","journal-title":"Lancet Psychiatry"},{"issue":"6","key":"4525_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-023-04852-9","volume":"61","author":"R Breitmeyer","year":"2023","unstructured":"Breitmeyer R, Vogel S, Heider J et al (2023) (2023) Regulation of synaptic connectivity in schizophrenia spectrum by mutual neuron-microglia interaction. Commun Biol 61(6):1\u201316. https:\/\/doi.org\/10.1038\/s42003-023-04852-9","journal-title":"Commun Biol"},{"key":"4525_CR36","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/S11064-025-04336-8","volume":"50","author":"Y Tizabi","year":"2025","unstructured":"Tizabi Y, Antonelli MC, Tizabi D, Aschner M (2025) Role of glial cells and receptors in schizophrenia pathogenesis. Neurochem Res 50:85. https:\/\/doi.org\/10.1007\/S11064-025-04336-8","journal-title":"Neurochem Res"},{"key":"4525_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/FNEUR.2020.593146","author":"IE Cisneros","year":"2020","unstructured":"Cisneros IE (2020) Methamphetamine activates trace amine associated receptor 1 to regulate astrocyte excitatory amino acid transporter-2 via differential CREB phosphorylation during HIV-associated neurocognitive disorders. Front Neurol. https:\/\/doi.org\/10.3389\/FNEUR.2020.593146","journal-title":"Front Neurol"},{"issue":"3","key":"4525_CR38","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/J.TINS.2018.12.004","volume":"42","author":"RA McCutcheon","year":"2019","unstructured":"McCutcheon RA, Abi-Dargham A, Howes OD (2019) Schizophrenia, dopamine and the striatum: from biology to symptoms. Trends Neurosci 42(3):205\u2013220. https:\/\/doi.org\/10.1016\/J.TINS.2018.12.004","journal-title":"Trends Neurosci"},{"key":"4525_CR39","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1176\/AJP.153.6.799;CTYPE:STRING:JOURNAL","volume":"153","author":"PE Cowell","year":"1996","unstructured":"Cowell PE, Kostianovsky DJ, Gur RC et al (1996) Sex differences in neuroanatomical and clinical correlations in schizophrenia. Am J Psychiatry 153:799\u2013805. https:\/\/doi.org\/10.1176\/AJP.153.6.799;CTYPE:STRING:JOURNAL","journal-title":"Am J Psychiatry"},{"key":"4525_CR40","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/S2215-0366(16)30348-0","volume":"4","author":"A Riecher-R\u00f6ssler","year":"2017","unstructured":"Riecher-R\u00f6ssler A (2017) Sex and gender differences in mental disorders. Lancet Psychiatry 4:8\u20139. https:\/\/doi.org\/10.1016\/S2215-0366(16)30348-0","journal-title":"Lancet Psychiatry"},{"key":"4525_CR41","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1001\/JAMAPSYCHIATRY.2014.2414","volume":"72","author":"M Slifstein","year":"2015","unstructured":"Slifstein M, Van De Giessen E, Van Snellenberg J et al (2015) Deficits in prefrontal cortical and extrastriatal dopamine release in schizophrenia a positron emission tomographic functional magnetic resonance imaging study. JAMA Psychiatr 72:316\u2013324. https:\/\/doi.org\/10.1001\/JAMAPSYCHIATRY.2014.2414","journal-title":"JAMA Psychiatr"},{"key":"4525_CR42","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/J.CMET.2021.07.006","volume":"33","author":"G Bonvento","year":"2021","unstructured":"Bonvento G, Bola\u00f1os JP (2021) Astrocyte-neuron metabolic cooperation shapes brain activity. Cell Metab 33:1546\u20131564. https:\/\/doi.org\/10.1016\/J.CMET.2021.07.006","journal-title":"Cell Metab"},{"key":"4525_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/J.CONB.2023.102797","volume":"83","author":"K Kim","year":"2023","unstructured":"Kim K, Picciotto MR (2023) Nicotine addiction: more than just dopamine. Curr Opin Neurobiol 83:102797. https:\/\/doi.org\/10.1016\/J.CONB.2023.102797","journal-title":"Curr Opin Neurobiol"},{"key":"4525_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/J.EJPHAR.2025.177408","author":"XY Yang","year":"2025","unstructured":"Yang XY, Wang HQ, Wang ZZ, Chen NH (2025) Linking depression and neuroinflammation: crosstalk between glial cells. Eur J Pharmacol. https:\/\/doi.org\/10.1016\/J.EJPHAR.2025.177408","journal-title":"Eur J Pharmacol"},{"key":"4525_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/FPHAR.2017.00905","author":"L Bellusci","year":"2017","unstructured":"Bellusci L, Laurino A, Sabatini M et al (2017) New insights into the potential roles of 3-Iodothyronamine (T1AM) and newly developed thyronamine-like TAAR1 agonists in neuroprotection. Front Pharmacol. https:\/\/doi.org\/10.3389\/FPHAR.2017.00905","journal-title":"Front Pharmacol"},{"key":"4525_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105271","author":"F Tozzi","year":"2021","unstructured":"Tozzi F, Rutigliano G, Bors\u00f2 M et al (2021) T1AM-TAAR1 signalling protects against OGD-induced synaptic dysfunction in the entorhinal cortex. Neurobiol Dis. https:\/\/doi.org\/10.1016\/j.nbd.2021.105271","journal-title":"Neurobiol Dis"},{"key":"4525_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS252111351","author":"S Park","year":"2024","unstructured":"Park S, Heu J, Hoener MC, Kilduff TS (2024) Wakefulness induced by TAAR1 partial agonism in mice is mediated through dopaminergic neurotransmission \u2020. Int J Mol Sci. https:\/\/doi.org\/10.3390\/IJMS252111351","journal-title":"Int J Mol Sci"},{"key":"4525_CR48","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/NPP.2016.216","volume":"42","author":"MD Schwartz","year":"2017","unstructured":"Schwartz MD, Black SW, Fisher SP et al (2017) Trace amine-associated receptor 1 regulates wakefulness and EEG spectral composition. Neuropsychopharmacology 42:1305\u20131314. https:\/\/doi.org\/10.1038\/NPP.2016.216","journal-title":"Neuropsychopharmacology"},{"key":"4525_CR49","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/(sici)1096-8628(200021)97:1<45::aid-ajmg6>3.0.co;2-9","volume":"97","author":"AS Bassett","year":"2000","unstructured":"Bassett AS, Chow EWC, Weksberg R (2000) Chromosomal abnormalities and schizophrenia. Am J Med Genet 97:45. https:\/\/doi.org\/10.1002\/(sici)1096-8628(200021)97:1%3c45::aid-ajmg6%3e3.0.co;2-9","journal-title":"Am J Med Genet"},{"key":"4525_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2024.101883","author":"N Dedic","year":"2024","unstructured":"Dedic N, Wang L, Hajos-Korcsok E et al (2024) TAAR1 agonists improve glycemic control, reduce body weight and modulate neurocircuits governing energy balance and feeding. Mol Metab. https:\/\/doi.org\/10.1016\/j.molmet.2024.101883","journal-title":"Mol Metab"},{"issue":"23","key":"4525_CR51","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/S12640-012-9348-1","volume":"232","author":"LL Hurley","year":"2012","unstructured":"Hurley LL (2012) Tizabi Y (2012) Neuroinflammation, neurodegeneration, and depression. Neurotox Res 232(23):131\u2013144. https:\/\/doi.org\/10.1007\/S12640-012-9348-1","journal-title":"Neurotox Res"},{"key":"4525_CR52","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/NRN1824","volume":"7","author":"NJ Abbott","year":"2006","unstructured":"Abbott NJ, R\u00f6nnb\u00e4ck L, Hansson E (2006) Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 7:41\u201353. https:\/\/doi.org\/10.1038\/NRN1824","journal-title":"Nat Rev Neurosci"},{"key":"4525_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/FNINS.2021.742065","author":"L Muzio","year":"2021","unstructured":"Muzio L, Viotti A, Martino G (2021) Microglia in neuroinflammation and neurodegeneration: from understanding to therapy. Front Neurosci. https:\/\/doi.org\/10.3389\/FNINS.2021.742065","journal-title":"Front Neurosci"},{"key":"4525_CR54","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.it.2015.08.005","volume":"36","author":"A Waisman","year":"2015","unstructured":"Waisman A, Ginhoux F, Greter M, Bruttger J (2015) Homeostasis of microglia in the adult brain: review of novel microglia depletion systems. Trends Immunol 36:625\u2013636. https:\/\/doi.org\/10.1016\/j.it.2015.08.005","journal-title":"Trends Immunol"},{"key":"4525_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222111576","author":"DA Barnes","year":"2021","unstructured":"Barnes DA, Galloway DA, Hoener MC et al (2021) Taar1 expression in human macrophages and brain tissue: a potential novel facet of MS neuroinflammation. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms222111576","journal-title":"Int J Mol Sci"},{"key":"4525_CR56","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1080\/08923973.2019.1672178","volume":"41","author":"KB Gwilt","year":"2019","unstructured":"Gwilt KB, Olliffe N, Hoffing RA, Miller GM (2019) Trace amine associated receptor 1 (TAAR1) expression and modulation of inflammatory cytokine production in mouse bone marrow-derived macrophages: a novel mechanism for inflammation in ulcerative colitis. Immunopharmacol Immunotoxicol 41:577\u2013585. https:\/\/doi.org\/10.1080\/08923973.2019.1672178","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"4525_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/BIOMEDICINES11102793","author":"F De Marchi","year":"2023","unstructured":"De Marchi F, Munitic I, Vidatic L et al (2023) Overlapping neuroimmune mechanisms and therapeutic targets in neurodegenerative disorders. Biomedicines. https:\/\/doi.org\/10.3390\/BIOMEDICINES11102793","journal-title":"Biomedicines"},{"key":"4525_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/J.MSARD.2023.104920","author":"O Belousova","year":"2023","unstructured":"Belousova O, Lopatina A, Kuzmina U, Melnikov M (2023) The role of biogenic amines in the modulation of monocytes in autoimmune neuroinflammation. Mult Scler Relat Disord. https:\/\/doi.org\/10.1016\/J.MSARD.2023.104920","journal-title":"Mult Scler Relat Disord"},{"key":"4525_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/IJMS21207777","volume":"21","author":"L Colucci-D\u2019amato","year":"2020","unstructured":"Colucci-D\u2019amato L, Speranza L, Volpicelli F (2020) Neurotrophic factor bdnf, physiological functions and therapeutic potential in depression, neurodegeneration and brain cancer. Int J Mol Sci 21:1\u201329. https:\/\/doi.org\/10.3390\/IJMS21207777","journal-title":"Int J Mol Sci"},{"key":"4525_CR60","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/978-3-031-36159-3_6","volume":"34","author":"AA Rasia-Filho","year":"2023","unstructured":"Rasia-Filho AA, Calcagnotto ME, von Bohlen und Halbach O, (2023) Glial cell modulation of dendritic spine structure and synaptic function. Adv Neurobiol 34:255\u2013310. https:\/\/doi.org\/10.1007\/978-3-031-36159-3_6","journal-title":"Adv Neurobiol"},{"key":"4525_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/CELLS8020184","author":"S Mahmoud","year":"2019","unstructured":"Mahmoud S, Gharagozloo M, Simard C, Gris D (2019) Astrocytes maintain glutamate homeostasis in the cns by controlling the balance between glutamate uptake and release. Cells. https:\/\/doi.org\/10.3390\/CELLS8020184","journal-title":"Cells"},{"key":"4525_CR62","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/J.ACTHIS.2007.10.003","volume":"110","author":"U Ndubaku","year":"2008","unstructured":"Ndubaku U, de Bellard ME (2008) Glial cells: old cells with new twists. Acta Histochem 110:182\u2013195. https:\/\/doi.org\/10.1016\/J.ACTHIS.2007.10.003","journal-title":"Acta Histochem"},{"key":"4525_CR63","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1093\/SCHBUL\/SBV191","volume":"42","author":"JL Kennedy","year":"2016","unstructured":"Kennedy JL, Xiong N, Yu J et al (2016) Increased nigral SLC6A3 activity in schizophrenia patients: findings from the toronto-mclean cohorts. Schizophr Bull 42:772\u2013781. https:\/\/doi.org\/10.1093\/SCHBUL\/SBV191","journal-title":"Schizophr Bull"},{"key":"4525_CR64","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/J.1749-6632.2010.05906.X","volume":"1216","author":"LE Eiden","year":"2011","unstructured":"Eiden LE, Weihe E (2011) VMAT2: a dynamic regulator of brain monoaminergic neuronal function interacting with drugs of abuse. Ann N Y Acad Sci 1216:86\u201398. https:\/\/doi.org\/10.1111\/J.1749-6632.2010.05906.X","journal-title":"Ann N Y Acad Sci"},{"key":"4525_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS23158543","author":"LG Harsing","year":"2022","unstructured":"Harsing LG, Knoll J, Miklya I (2022) Enhancer regulation of dopaminergic neurochemical transmission in the striatum. Int J Mol Sci. https:\/\/doi.org\/10.3390\/IJMS23158543","journal-title":"Int J Mol Sci"},{"key":"4525_CR66","doi-asserted-by":"publisher","DOI":"10.1192\/J.EURPSY.2021.1","volume":"64","author":"Y-S Hsueh","year":"2021","unstructured":"Hsueh Y-S, Lin C-Y, Chiu N-T et al (2021) Changes in striatal dopamine transporters in bipolar disorder and valproate treatment. Eur Psychiatry 64:e9. https:\/\/doi.org\/10.1192\/J.EURPSY.2021.1","journal-title":"Eur Psychiatry"},{"key":"4525_CR67","doi-asserted-by":"publisher","DOI":"10.1124\/JPET.119.258970","author":"NB Miner","year":"2019","unstructured":"Miner NB, Phillips TJ, Janowsky A (2019) The role of biogenic amine transporters in trace amine\u2013associated receptor 1 regulation of methamphetamine-induced neurotoxicity. J Pharmacol Exp Ther. https:\/\/doi.org\/10.1124\/JPET.119.258970","journal-title":"J Pharmacol Exp Ther"},{"key":"4525_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/S41380-018-0226-Y","author":"F Petrelli","year":"2018","unstructured":"Petrelli F, Dall\u00e9rac G, Pucci L et al (2018) Dysfunction of homeostatic control of dopamine by astrocytes in the developing prefrontal cortex leads to cognitive impairments. Mol Psychiatry. https:\/\/doi.org\/10.1038\/S41380-018-0226-Y","journal-title":"Mol Psychiatry"},{"key":"4525_CR69","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1124\/MOL.111.073304","volume":"80","author":"S Espinoza","year":"2011","unstructured":"Espinoza S, Salahpour A, Masri B et al (2011) Functional interaction between trace amine-associated receptor 1 and dopamine D2 receptor. Mol Pharmacol 80:416\u2013425. https:\/\/doi.org\/10.1124\/MOL.111.073304","journal-title":"Mol Pharmacol"},{"key":"4525_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2025.111278","volume":"137","author":"JL de Deus","year":"2025","unstructured":"de Deus JL, Maia JM, Soriano RN et al (2025) Psychedelics in neuroinflammation: mechanisms and therapeutic potential. Prog Neuropsychopharmacol Biol Psychiatry 137:111278. https:\/\/doi.org\/10.1016\/j.pnpbp.2025.111278","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"4525_CR71","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1124\/PR.115.011478","volume":"68","author":"DE Nichols","year":"2016","unstructured":"Nichols DE (2016) Psychedelics. Pharmacol Rev 68:264\u2013355. https:\/\/doi.org\/10.1124\/PR.115.011478","journal-title":"Pharmacol Rev"},{"key":"4525_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/S41537-023-00370-Z","volume":"9","author":"C Zhuo","year":"2023","unstructured":"Zhuo C, Tian H, Song X et al (2023) Microglia and cognitive impairment in schizophrenia: translating scientific progress into novel therapeutic interventions. Schizophrenia 9:1\u20138. https:\/\/doi.org\/10.1038\/S41537-023-00370-Z","journal-title":"Schizophrenia"},{"key":"4525_CR73","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/S40263-024-01151-7","volume":"39","author":"P Govil","year":"2025","unstructured":"Govil P, Kantrowitz JT (2025) Negative symptoms in schizophrenia: an update on research assessment and the current and upcoming treatment landscape. CNS Drugs 39:243\u2013262. https:\/\/doi.org\/10.1007\/S40263-024-01151-7","journal-title":"CNS Drugs"},{"key":"4525_CR74","doi-asserted-by":"publisher","DOI":"10.3389\/FPHAR.2018.00279","author":"JF Liu","year":"2018","unstructured":"Liu JF, Li JX (2018) TAAR1 in addiction: looking beyond the tip of the iceberg. Front Pharmacol. https:\/\/doi.org\/10.3389\/FPHAR.2018.00279","journal-title":"Front Pharmacol"},{"key":"4525_CR75","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1006\/exnr.1999.7105","volume":"158","author":"C Wu","year":"1999","unstructured":"Wu C, Singh SK, Dias P et al (1999) Activated astrocytes display increased 5-HT2a receptor expression in pathological states. Exp Neurol 158:529\u2013533. https:\/\/doi.org\/10.1006\/exnr.1999.7105","journal-title":"Exp Neurol"},{"key":"4525_CR76","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.ebiom.2016.08.049","volume":"11","author":"DA Martin","year":"2016","unstructured":"Martin DA, Nichols CD (2016) Psychedelics recruit multiple cellular types and produce complex transcriptional responses within the brain. EBioMedicine 11:262\u2013277. https:\/\/doi.org\/10.1016\/j.ebiom.2016.08.049","journal-title":"EBioMedicine"},{"key":"4525_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s41537-021-00190-z","author":"CU Correll","year":"2021","unstructured":"Correll CU, Koblan KS, Hopkins SC et al (2021) Safety and effectiveness of ulotaront (SEP-363856) in schizophrenia: results of a 6-month, open-label extension study. Npj Schizophr. https:\/\/doi.org\/10.1038\/s41537-021-00190-z","journal-title":"Npj Schizophr"},{"key":"4525_CR78","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.2147\/NDT.S501560","volume":"20","author":"M Luca","year":"2024","unstructured":"Luca M, Luca A, Serretti A (2024) A clinically oriented review of new antipsychotics for schizophrenia. Neuropsychiatr Dis Treat 20:2637\u20132649. https:\/\/doi.org\/10.2147\/NDT.S501560","journal-title":"Neuropsychiatr Dis Treat"},{"key":"4525_CR79","doi-asserted-by":"publisher","DOI":"10.3390\/BIOMEDICINES12061263","author":"TS Shemiakova","year":"2024","unstructured":"Shemiakova TS, Efimova EV, Gainetdinov RR (2024) TAARs as novel therapeutic targets for the treatment of depression: a narrative review of the interconnection with monoamines and adult neurogenesis. Biomedicines. https:\/\/doi.org\/10.3390\/BIOMEDICINES12061263","journal-title":"Biomedicines"},{"key":"4525_CR80","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.biocel.2006.10.022","volume":"39","author":"F He","year":"2007","unstructured":"He F, Sun YE (2007) Glial cells more than support cells? Int J Biochem Cell Biol 39:661\u2013665. https:\/\/doi.org\/10.1016\/j.biocel.2006.10.022","journal-title":"Int J Biochem Cell Biol"},{"key":"4525_CR81","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1152\/physrev.00042.2016","volume":"98","author":"A Verkhratsky","year":"2018","unstructured":"Verkhratsky A, Nedergaard M (2018) Physiology of astroglia. Physiol Rev 98:239\u2013389. https:\/\/doi.org\/10.1152\/physrev.00042.2016","journal-title":"Physiol Rev"},{"key":"4525_CR82","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-3-030-77375-5_1","volume":"26","author":"C Scuderi","year":"2021","unstructured":"Scuderi C, Verkhratsky A, Parpura V, Li B (2021) Neuroglia in Psychiatric Disorders Adv Neurobiol 26:3\u201319. https:\/\/doi.org\/10.1007\/978-3-030-77375-5_1","journal-title":"Neuroglia in Psychiatric Disorders Adv Neurobiol"},{"key":"4525_CR83","doi-asserted-by":"publisher","DOI":"10.1177\/02698811241249415","author":"GP Reynolds","year":"2024","unstructured":"Reynolds GP (2024) The trace amine-associated receptor 1 agonists \u2013 non-dopaminergic antipsychotics or covert modulators of D2 receptors? J Psychopharmacol. https:\/\/doi.org\/10.1177\/02698811241249415","journal-title":"J Psychopharmacol"},{"key":"4525_CR84","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2278-22.2024","volume":"44","author":"R Heir","year":"2024","unstructured":"Heir R, Abbasi Z, Komal P et al (2024) Astrocytes are the source of TNF mediating homeostatic synaptic plasticity. J Neurosci 44:e2278222024. https:\/\/doi.org\/10.1523\/JNEUROSCI.2278-22.2024","journal-title":"J Neurosci"},{"key":"4525_CR85","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.3390\/ijms19103033","volume":"19","author":"JM Robertson","year":"2018","unstructured":"Robertson JM (2018) The gliocentric brain. Int J Mol Sci 19:3033","journal-title":"Int J Mol Sci"},{"key":"4525_CR86","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1080\/13543784.2023.2206559","volume":"32","author":"GH Le","year":"2023","unstructured":"Le GH, Gillissie ES, Rhee TG et al (2023) Efficacy, safety, and tolerability of ulotaront (SEP-363856, a trace amine-associated receptor 1 agonist) for the treatment of schizophrenia and other mental disorders: a systematic review of preclinical and clinical trials. Expert Opin Investig Drugs 32:401\u2013415. https:\/\/doi.org\/10.1080\/13543784.2023.2206559","journal-title":"Expert Opin Investig Drugs"},{"key":"4525_CR87","doi-asserted-by":"publisher","DOI":"10.3389\/FNCEL.2017.00024","author":"S J\u00e4kel","year":"2017","unstructured":"J\u00e4kel S, Dimou L (2017) Glial Cells and their function in the adult brain: a journey through the history of their ablation. Front Cell Neurosci. https:\/\/doi.org\/10.3389\/FNCEL.2017.00024","journal-title":"Front Cell Neurosci"},{"key":"4525_CR88","doi-asserted-by":"publisher","DOI":"10.3389\/FNETP.2023.1205544","author":"SS Purushotham","year":"2023","unstructured":"Purushotham SS, Buskila Y (2023) Astrocytic modulation of neuronal signalling. Front Netw Physiol. https:\/\/doi.org\/10.3389\/FNETP.2023.1205544","journal-title":"Front Netw Physiol"},{"key":"4525_CR89","doi-asserted-by":"publisher","DOI":"10.3390\/BRAINSCI14060558","author":"Y Tizabi","year":"2024","unstructured":"Tizabi Y, Getachew B, Hauser SR et al (2024) Role of glial cells in neuronal function, mood disorders, and drug addiction. Brain Sci. https:\/\/doi.org\/10.3390\/BRAINSCI14060558","journal-title":"Brain Sci"},{"key":"4525_CR90","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1515\/revneuro-2020-0012","volume":"32","author":"D Dere","year":"2020","unstructured":"Dere D, Zlomuzica A, Dere E (2020) Channels to consciousness: a possible role of gap junctions in consciousness. Rev Neurosci 32:101\u2013129. https:\/\/doi.org\/10.1515\/revneuro-2020-0012","journal-title":"Rev Neurosci"},{"key":"4525_CR91","doi-asserted-by":"publisher","DOI":"10.3389\/FNCEL.2015.00340\/BIBTEX","volume":"9","author":"JP Michalski","year":"2015","unstructured":"Michalski JP, Kothary R (2015) Oligodendrocytes in a nutshell. Front Cell Neurosci 9:158759. https:\/\/doi.org\/10.3389\/FNCEL.2015.00340\/BIBTEX","journal-title":"Front Cell Neurosci"},{"key":"4525_CR92","doi-asserted-by":"publisher","DOI":"10.3389\/FENDO.2022.953995\/BIBTEX","volume":"13","author":"RW Clayton","year":"2022","unstructured":"Clayton RW, Lovell-Badge R, Galichet C (2022) The properties and functions of glial cell types of the hypothalamic median eminence. Front Endocrinol (Lausanne) 13:953995. https:\/\/doi.org\/10.3389\/FENDO.2022.953995\/BIBTEX","journal-title":"Front Endocrinol (Lausanne)"},{"key":"4525_CR93","doi-asserted-by":"publisher","first-page":"1169320","DOI":"10.3389\/FNMOL.2023.1169320\/BIBTEX","volume":"16","author":"D Pathak","year":"2023","unstructured":"Pathak D, Sriram K (2023) Neuron-astrocyte omnidirectional signaling in neurological health and disease. Front Mol Neurosci 16:1169320. https:\/\/doi.org\/10.3389\/FNMOL.2023.1169320\/BIBTEX","journal-title":"Front Mol Neurosci"},{"key":"4525_CR94","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/B978-0-444-52001-2.00004-2","volume":"122","author":"C Lubetzki","year":"2014","unstructured":"Lubetzki C, Stankoff B (2014) Demyelination in multiple sclerosis. Handb Clin Neurol 122:89\u201399. https:\/\/doi.org\/10.1016\/B978-0-444-52001-2.00004-2","journal-title":"Handb Clin Neurol"},{"issue":"4","key":"4525_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/J.MOLPHA.2025.100027","volume":"107","author":"K Chen","year":"2025","unstructured":"Chen K, Park E, Abd-Elrahman KS (2025) Enhancing remyelination in multiple sclerosis via M1 muscarinic acetylcholine receptor. Mol Pharmacol 107(4):100027. https:\/\/doi.org\/10.1016\/J.MOLPHA.2025.100027","journal-title":"Mol Pharmacol"},{"key":"4525_CR96","doi-asserted-by":"publisher","DOI":"10.1007\/S00213-024-06632-7","author":"X Wang","year":"2024","unstructured":"Wang X, Fu J, Wang H et al (2024) Glia dysfunction in schizophrenia: evidence of possible therapeutic effects of nervonic acid in a preclinical model. Psychopharmacology. https:\/\/doi.org\/10.1007\/S00213-024-06632-7","journal-title":"Psychopharmacology"},{"key":"4525_CR97","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.591690","volume":"11","author":"QP Verhoog","year":"2020","unstructured":"Verhoog QP, Holtman L, Aronica E, van Vliet EA (2020) Astrocytes as guardians of neuronal excitability: mechanisms underlying epileptogenesis. Front Neurol 11:591690. https:\/\/doi.org\/10.3389\/fneur.2020.591690","journal-title":"Front Neurol"},{"key":"4525_CR98","doi-asserted-by":"publisher","DOI":"10.3389\/FNCEL.2021.718324\/BIBTEX","volume":"15","author":"KL Hanslik","year":"2021","unstructured":"Hanslik KL, Marino KM, Ulland TK (2021) Modulation of glial function in health, aging, and neurodegenerative disease. Front Cell Neurosci 15:718324. https:\/\/doi.org\/10.3389\/FNCEL.2021.718324\/BIBTEX","journal-title":"Front Cell Neurosci"},{"key":"4525_CR99","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/J.NEURO.2017.09.006","volume":"63","author":"NB Miner","year":"2017","unstructured":"Miner NB, Elmore JS, Baumann MH et al (2017) Trace amine-associated receptor 1 regulation of methamphetamine-induced neurotoxicity. Neurotoxicology 63:57\u201369. https:\/\/doi.org\/10.1016\/J.NEURO.2017.09.006","journal-title":"Neurotoxicology"},{"key":"4525_CR100","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s44220-023-00034-y","volume":"13","author":"AS Hatoum","year":"2023","unstructured":"Hatoum AS, Colbert SMC, Johnson EC et al (2023) (2023) Multivariate genome-wide association meta-analysis of over 1 million subjects identifies loci underlying multiple substance use disorders. Nat Ment Heal. 13:210\u2013223. https:\/\/doi.org\/10.1038\/s44220-023-00034-y","journal-title":"Nat Ment Heal."},{"issue":"28","key":"4525_CR101","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/s41380-022-01838-7","volume":"282","author":"G Poggi","year":"2022","unstructured":"Poggi G, Wennstr\u00f6m M, M\u00fcller MB (2022) Treccani G (2022) NG2-glia: rising stars in stress-related mental disorders? Mol Psychiatry 282(28):518\u2013520. https:\/\/doi.org\/10.1038\/s41380-022-01838-7","journal-title":"Mol Psychiatry"},{"key":"4525_CR102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12974-020-02043-5\/FIGURES\/8","volume":"17","author":"LA Bell","year":"2020","unstructured":"Bell LA, Wallis GJ, Wilcox KS (2020) Reactivity and increased proliferation of NG2 cells following central nervous system infection with Theiler\u2019s murine encephalomyelitis virus. J Neuroinflammation 17:1\u201314. https:\/\/doi.org\/10.1186\/S12974-020-02043-5\/FIGURES\/8","journal-title":"J Neuroinflammation"},{"key":"4525_CR103","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/B978-0-08-046884-6.01313-0","volume":"13","author":"M Aschner","year":"2010","unstructured":"Aschner M, Philbert MA (2010) Glial Cells Compr Toxicol Second Ed 13:199\u2013219. https:\/\/doi.org\/10.1016\/B978-0-08-046884-6.01313-0","journal-title":"Glial Cells Compr Toxicol Second Ed"},{"key":"4525_CR104","doi-asserted-by":"publisher","DOI":"10.3389\/FNINS.2015.00372","author":"N M\u00fcller","year":"2015","unstructured":"M\u00fcller N, Weidinger E, Leitner B, Schwarz MJ (2015) The role of inflammation in schizophrenia. Front Neurosci. https:\/\/doi.org\/10.3389\/FNINS.2015.00372","journal-title":"Front Neurosci"},{"key":"4525_CR105","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.3390\/IJMS23052810","volume":"23","author":"A Vall\u00e9e","year":"2022","unstructured":"Vall\u00e9e A (2022) Neuroinflammation in schizophrenia: the key role of the wnt\/\u03b2-catenin pathway. Int J Mol Sci 23:2810. https:\/\/doi.org\/10.3390\/IJMS23052810","journal-title":"Int J Mol Sci"},{"key":"4525_CR106","doi-asserted-by":"publisher","DOI":"10.1038\/S41467-020-14628-Y","author":"TY Eom","year":"2020","unstructured":"Eom TY, Han SB, Kim J et al (2020) Schizophrenia-related microdeletion causes defective ciliary motility and brain ventricle enlargement via microRNA-dependent mechanisms in mice. Nat Commun. https:\/\/doi.org\/10.1038\/S41467-020-14628-Y","journal-title":"Nat Commun"},{"key":"4525_CR107","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/J.NEUROPHARM.2014.06.011","volume":"85","author":"IE Cisneros","year":"2014","unstructured":"Cisneros IE, Ghorpade A (2014) Methamphetamine and HIV-1-induced neurotoxicity: role of trace amine associated receptor 1 cAMP signaling in astrocytes. Neuropharmacology 85:499\u2013507. https:\/\/doi.org\/10.1016\/J.NEUROPHARM.2014.06.011","journal-title":"Neuropharmacology"},{"key":"4525_CR108","doi-asserted-by":"publisher","DOI":"10.1007\/S11481-011-9321-4","author":"MW Panas","year":"2012","unstructured":"Panas MW, Xie Z, Panas HN et al (2012) Trace amine associated receptor 1 signaling in activated lymphocytes. J Neuroimmune Pharmacol. https:\/\/doi.org\/10.1007\/S11481-011-9321-4","journal-title":"J Neuroimmune Pharmacol"},{"key":"4525_CR109","doi-asserted-by":"publisher","DOI":"10.3390\/BIOMEDICINES12071590\/S1","author":"AN Vaganova","year":"2024","unstructured":"Vaganova AN, Markina AA, Belousov AM et al (2024) Dopamine receptors and TAAR1 functional interaction patterns in the duodenum are impaired in gastrointestinal disorders. Biomedicines. https:\/\/doi.org\/10.3390\/BIOMEDICINES12071590\/S1","journal-title":"Biomedicines"},{"key":"4525_CR110","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1021\/ACSMEDCHEMLETT.1C00527\/ASSET\/IMAGES\/LARGE\/ML1C00527_0001.JPEG","volume":"13","author":"MLR Heffernan","year":"2022","unstructured":"Heffernan MLR, Herman LW, Brown S et al (2022) Ulotaront: a TAAR1 agonist for the treatment of schizophrenia. ACS Med Chem Lett 13:92\u201398. https:\/\/doi.org\/10.1021\/ACSMEDCHEMLETT.1C00527\/ASSET\/IMAGES\/LARGE\/ML1C00527_0001.JPEG","journal-title":"ACS Med Chem Lett"},{"key":"4525_CR111","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.tins.2022.10.010","volume":"46","author":"EF Halff","year":"2023","unstructured":"Halff EF, Rutigliano G, Garcia-Hidalgo A, Howes OD (2023) Trace amine-associated receptor 1 (TAAR1) agonism as a new treatment strategy for schizophrenia and related disorders. Trends Neurosci 46:60\u201374. https:\/\/doi.org\/10.1016\/j.tins.2022.10.010","journal-title":"Trends Neurosci"},{"key":"4525_CR112","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/J.1749-6632.2009.04014.X","volume":"1170","author":"SD Liberles","year":"2009","unstructured":"Liberles SD (2009) Trace amine-associated receptors are olfactory receptors in vertebrates. Ann N Y Acad Sci 1170:168\u2013172. https:\/\/doi.org\/10.1111\/J.1749-6632.2009.04014.X","journal-title":"Ann N Y Acad Sci"},{"key":"4525_CR113","doi-asserted-by":"publisher","first-page":"12241","DOI":"10.1523\/JNEUROSCI.1779-14.2014","volume":"34","author":"LF Horowitz","year":"2014","unstructured":"Horowitz LF, Saraiva LR, Kuang D et al (2014) Olfactory receptor patterning in a higher primate. J Neurosci 34:12241\u201312252. https:\/\/doi.org\/10.1523\/JNEUROSCI.1779-14.2014","journal-title":"J Neurosci"},{"key":"4525_CR114","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaz5390","author":"L Xu","year":"2020","unstructured":"Xu L, Li W, Voleti V et al (2020) Widespread receptor-driven modulation in peripheral olfactory coding. Science. https:\/\/doi.org\/10.1126\/science.aaz5390","journal-title":"Science"},{"key":"4525_CR115","doi-asserted-by":"publisher","DOI":"10.3389\/FPSYT.2024.1464550","author":"B Shajan","year":"2024","unstructured":"Shajan B, Bastiampillai T, Hellyer SD, Nair PC (2024) Unlocking the secrets of trace amine-associated receptor 1 agonists: new horizon in neuropsychiatric treatment. Front Psychiatry. https:\/\/doi.org\/10.3389\/FPSYT.2024.1464550","journal-title":"Front Psychiatry"},{"key":"4525_CR116","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-023-44601-4","volume":"151","author":"G Zilberg","year":"2024","unstructured":"Zilberg G, Parpounas AK, Warren AL et al (2024) (2024) Molecular basis of human trace amine-associated receptor 1 activation. Nat Commun 151:1\u201314. https:\/\/doi.org\/10.1038\/s41467-023-44601-4","journal-title":"Nat Commun"},{"key":"4525_CR117","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/S41598-021-87236-5","volume":"11","author":"M Dieris","year":"2021","unstructured":"Dieris M, Kowatschew D, Korsching SI (2021) Olfactory function in the trace amine-associated receptor family (TAARs) evolved twice independently. Sci Rep 11:1\u201317. https:\/\/doi.org\/10.1038\/S41598-021-87236-5","journal-title":"Sci Rep"},{"key":"4525_CR118","doi-asserted-by":"publisher","DOI":"10.1016\/J.EJPHAR.2025.177312","author":"DS Galstyan","year":"2025","unstructured":"Galstyan DS, Krotova NA, Lebedev AS et al (2025) Trace amine signaling in zebrafish models: CNS pharmacology, behavioral regulation and translational relevance. Eur J Pharmacol. https:\/\/doi.org\/10.1016\/J.EJPHAR.2025.177312","journal-title":"Eur J Pharmacol"},{"key":"4525_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/J.BCP.2024.116376","volume":"228","author":"JT Coyle","year":"2024","unstructured":"Coyle JT (2024) Passing the torch: the ascendance of the glutamatergic synapse in the pathophysiology of schizophrenia. Biochem Pharmacol 228:116376. https:\/\/doi.org\/10.1016\/J.BCP.2024.116376","journal-title":"Biochem Pharmacol"},{"key":"4525_CR120","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1093\/MOLBEV\/MSM140","volume":"24","author":"Y Hashiguchi","year":"2007","unstructured":"Hashiguchi Y, Nishida M (2007) Evolution of trace amine associated receptor (TAAR) gene family in vertebrates: lineage-specific expansions and degradations of a second class of vertebrate chemosensory receptors expressed in the olfactory epithelium. Mol Biol Evol 24:2099\u20132107. https:\/\/doi.org\/10.1093\/MOLBEV\/MSM140","journal-title":"Mol Biol Evol"},{"key":"4525_CR121","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1093\/SCHBUL\/SBAD148","volume":"50","author":"T Imbriglio","year":"2024","unstructured":"Imbriglio T, Alborghetti M, Bruno V et al (2024) Up-regulation of the trace amine receptor, TAAR-1, in the prefrontal cortex of individuals affected by schizophrenia. Schizophr Bull 50:374\u2013381. https:\/\/doi.org\/10.1093\/SCHBUL\/SBAD148","journal-title":"Schizophr Bull"},{"key":"4525_CR122","doi-asserted-by":"publisher","DOI":"10.3389\/FPHAR.2017.00987\/BIBTEX","author":"G Rutigliano","year":"2018","unstructured":"Rutigliano G, Accorroni A, Zucchi R (2018) The case for TAAR1 as a modulator of central nervous system function. Front Pharmacol. https:\/\/doi.org\/10.3389\/FPHAR.2017.00987\/BIBTEX","journal-title":"Front Pharmacol"},{"key":"4525_CR123","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/hep.30150.Ductular","volume":"176","author":"J Jibin","year":"2017","unstructured":"Jibin J, Prachi K, Triptish B et al (2017) Possible role of rare variants in trace amine associated receptor 1 in schizophrenia. Physiol Behav 176:139\u2013148. https:\/\/doi.org\/10.1002\/hep.30150.Ductular","journal-title":"Physiol Behav"},{"key":"4525_CR124","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/mp.2012.57","volume":"185","author":"FG Revel","year":"2013","unstructured":"Revel FG, Moreau JL, Pouzet B et al (2013) (2012) A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight. Mol Psychiatry 185:543\u2013556. https:\/\/doi.org\/10.1038\/mp.2012.57","journal-title":"Mol Psychiatry"},{"key":"4525_CR125","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.neuropharm.2014.02.007","volume":"81","author":"D Leo","year":"2014","unstructured":"Leo D, Mus L, Espinoza S et al (2014) Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: role of D2 dopamine autoreceptors. Neuropharmacology 81:283\u2013291. https:\/\/doi.org\/10.1016\/j.neuropharm.2014.02.007","journal-title":"Neuropharmacology"},{"key":"4525_CR126","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3389\/fphar.2025.1598048","volume":"1","author":"Z Li","year":"2025","unstructured":"Li Z, Wan L, Dong J, Li J (2025) Trace amine-associated receptors as potential targets for the treatment of anxiety and depression. Front Pharmacol 1:8. https:\/\/doi.org\/10.3389\/fphar.2025.1598048","journal-title":"Front Pharmacol"},{"key":"4525_CR127","doi-asserted-by":"publisher","DOI":"10.3390\/BIOM12121823\/S1","author":"IS Zhukov","year":"2022","unstructured":"Zhukov IS, Vaganova AN, Murtazina RZ et al (2022) Gut microbiota alterations in trace amine-associated receptor 9 (TAAR9) knockout rats. Biomolecules. https:\/\/doi.org\/10.3390\/BIOM12121823\/S1","journal-title":"Biomolecules"},{"key":"4525_CR128","doi-asserted-by":"publisher","DOI":"10.1016\/J.CELL.2023.10.014\/ASSET\/26914453-0381-453D-B85A-FBE5EF66C270\/MAIN.ASSETS\/GR1.JPG","author":"P Shang","year":"2023","unstructured":"Shang P, Rong N, Jiang JJ et al (2023) Structural and signaling mechanisms of TAAR1 enabled preferential agonist design. Cell. https:\/\/doi.org\/10.1016\/J.CELL.2023.10.014\/ASSET\/26914453-0381-453D-B85A-FBE5EF66C270\/MAIN.ASSETS\/GR1.JPG","journal-title":"Cell"},{"key":"4525_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114505","volume":"43","author":"K Jiang","year":"2024","unstructured":"Jiang K, Zheng Y, Zeng L et al (2024) The versatile binding landscape of the TAAR1 pocket for LSD and other antipsychotic drug molecules. Cell Rep 43:114505. https:\/\/doi.org\/10.1016\/j.celrep.2024.114505","journal-title":"Cell Rep"},{"key":"4525_CR130","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1124\/JPET.106.112532","volume":"320","author":"DB Wainscott","year":"2007","unstructured":"Wainscott DB, Little SP, Yin T et al (2007) Pharmacologic characterization of the cloned human trace amine-associated receptor1 (TAAR1) and evidence for species differences with the rat TAAR1. J Pharmacol Exp Ther 320:475\u2013485. https:\/\/doi.org\/10.1124\/JPET.106.112532","journal-title":"J Pharmacol Exp Ther"},{"key":"4525_CR131","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.120553","author":"S Liao","year":"2022","unstructured":"Liao S, Pino MJ, Deleon C et al (2022) Interaction analyses of hTAAR1 and mTAAR1 with antagonist EPPTB. Life Sci. https:\/\/doi.org\/10.1016\/j.lfs.2022.120553","journal-title":"Life Sci"},{"key":"4525_CR132","doi-asserted-by":"publisher","first-page":"11569","DOI":"10.3390\/IJMS241411569","volume":"24","author":"B Polini","year":"2023","unstructured":"Polini B, Ricardi C, Bertolini A et al (2023) T1AM\/TAAR1 System reduces inflammatory response and \u03b2-Amyloid toxicity in human microglial HMC3 cell line. Int J Mol Sci 24:11569. https:\/\/doi.org\/10.3390\/IJMS241411569","journal-title":"Int J Mol Sci"},{"key":"4525_CR133","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1080\/14728222.2018.1480723","volume":"22","author":"MD Schwartz","year":"2018","unstructured":"Schwartz MD, Canales JJ, Zucchi R et al (2018) Trace amine-associated receptor 1: a multimodal therapeutic target for neuropsychiatric diseases. Expert Opin Ther Targets 22:513\u2013526. https:\/\/doi.org\/10.1080\/14728222.2018.1480723","journal-title":"Expert Opin Ther Targets"},{"key":"4525_CR134","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1124\/JPET.105.084459","volume":"313","author":"GM Miller","year":"2005","unstructured":"Miller GM, Verrico CD, Jassen A et al (2005) Primate trace amine receptor 1 modulation by the dopamine transporter. J Pharmacol Exp Ther 313:983\u2013994. https:\/\/doi.org\/10.1124\/JPET.105.084459","journal-title":"J Pharmacol Exp Ther"},{"key":"4525_CR135","doi-asserted-by":"publisher","DOI":"10.3390\/BIOMEDICINES12092114","author":"Z Fesenko","year":"2024","unstructured":"Fesenko Z, Ptukha M, da Silva MM et al (2024) Electrophysiological and behavioral markers of hyperdopaminergia in DAT-KO Rats. Biomed. https:\/\/doi.org\/10.3390\/BIOMEDICINES12092114","journal-title":"Biomed"},{"key":"4525_CR136","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1093\/SCHBUL\/SBW192","volume":"43","author":"E Artiges","year":"2017","unstructured":"Artiges E, Leroy C, Dubol M et al (2017) Striatal and extrastriatal dopamine transporter availability in schizophrenia and its clinical correlates: a voxel-based and high-resolution PET study. Schizophr Bull 43:1134\u20131142. https:\/\/doi.org\/10.1093\/SCHBUL\/SBW192","journal-title":"Schizophr Bull"},{"key":"4525_CR137","doi-asserted-by":"publisher","DOI":"10.1016\/J.NBD.2025.106839","author":"N Granado","year":"2025","unstructured":"Granado N, Mendieta L, Tizabi Y et al (2025) Attenuated neurotoxicity after repeated methamphetamine binges linked to dopamine transporter (DAT) decline. Neurobiol Dis. https:\/\/doi.org\/10.1016\/J.NBD.2025.106839","journal-title":"Neurobiol Dis"},{"key":"4525_CR138","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1038\/S41386-022-01301-9","volume":"47","author":"D De Gregorio","year":"2022","unstructured":"De Gregorio D, Inserra A, Enns JP et al (2022) Repeated lysergic acid diethylamide (LSD) reverses stress-induced anxiety-like behavior, cortical synaptogenesis deficits and serotonergic neurotransmission decline. Neuropsychopharmacology 47:1188\u20131198. https:\/\/doi.org\/10.1038\/S41386-022-01301-9","journal-title":"Neuropsychopharmacology"},{"key":"4525_CR139","doi-asserted-by":"publisher","first-page":"8485","DOI":"10.1073\/PNAS.1103029108","volume":"108","author":"FG Revel","year":"2011","unstructured":"Revel FG, Moreau JL, Gainetdinov RR et al (2011) TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity. Proc Natl Acad Sci U S A 108:8485\u20138490. https:\/\/doi.org\/10.1073\/PNAS.1103029108","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4525_CR140","doi-asserted-by":"publisher","DOI":"10.3390\/BIOMEDICINES11071977","author":"SR Kuvarzin","year":"2023","unstructured":"Kuvarzin SR, Sukhanov I, Onokhin K et al (2023) Unlocking the therapeutic potential of Ulotaront as a trace amine-associated receptor 1 agonist for neuropsychiatric disorders. Biomedicines. https:\/\/doi.org\/10.3390\/BIOMEDICINES11071977","journal-title":"Biomedicines"},{"key":"4525_CR141","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.schres.2017.04.016","volume":"194","author":"JY Khokhar","year":"2018","unstructured":"Khokhar JY, Dwiel LL, Henricks AM et al (2018) The link between schizophrenia and substance use disorder: a unifying hypothesis. Schizophr Res 194:78\u201385. https:\/\/doi.org\/10.1016\/j.schres.2017.04.016","journal-title":"Schizophr Res"},{"key":"4525_CR142","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2016.233","author":"A Ferragud","year":"2016","unstructured":"Ferragud A, Howell AD, Moore CF et al (2016) The trace amine-associated receptor 1 agonist RO5256390 blocks compulsive Binge-like Eating in Rats. Neuropsychopharmacol. https:\/\/doi.org\/10.1038\/npp.2016.233","journal-title":"Neuropsychopharmacol"},{"key":"4525_CR143","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1017\/S1092852920000541","volume":"25","author":"KS Koblan","year":"2020","unstructured":"Koblan KS, Hopkins S, Kent J et al (2020) 138 efficacy and safety of SEP-363856, a novel psychotropic agent with a non-D2 mechanism of action, in the treatment of schizophrenia. CNS Spectr 25:287\u2013288. https:\/\/doi.org\/10.1017\/S1092852920000541","journal-title":"CNS Spectr"},{"key":"4525_CR144","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/J.FREERADBIOMED.2022.02.020","volume":"182","author":"Z Jiwaji","year":"2022","unstructured":"Jiwaji Z, Hardingham GE (2022) Good, bad, and neglectful: astrocyte changes in neurodegenerative disease. Free Radic Biol Med 182:93\u201399. https:\/\/doi.org\/10.1016\/J.FREERADBIOMED.2022.02.020","journal-title":"Free Radic Biol Med"},{"key":"4525_CR145","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1006\/nbdi.2001.0437","volume":"8","author":"A Nagai","year":"2001","unstructured":"Nagai A, Nakagawa E, Hatori K et al (2001) Generation and characterization of immortalized human microglial cell lines: expression of cytokines and chemokines. Neurobiol Dis 8:1057\u20131068. https:\/\/doi.org\/10.1006\/nbdi.2001.0437","journal-title":"Neurobiol Dis"},{"key":"4525_CR146","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/916198","author":"S Ochoa","year":"2012","unstructured":"Ochoa S, Usall J, Jes\u00b4 J, et al (2012) Gender differences in schizophrenia and first-episode psychosis: a comprehensive literature review. Schizophr Res Treat. https:\/\/doi.org\/10.1155\/2012\/916198","journal-title":"Schizophr Res Treat"},{"key":"4525_CR147","doi-asserted-by":"publisher","first-page":"607","DOI":"10.2147\/NDT.S455279","volume":"20","author":"A Peng","year":"2024","unstructured":"Peng A, Chai J, Wu H et al (2024) New therapeutic targets and drugs for schizophrenia beyond dopamine D2 receptor antagonists. Neuropsychiatr Dis Treat 20:607\u2013620. https:\/\/doi.org\/10.2147\/NDT.S455279","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"6","key":"4525_CR148","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/J.TINS.2015.04.003","volume":"38","author":"Z Yang","year":"2015","unstructured":"Yang Z, Wang KKW (2015) Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker. Trends Neurosci 38(6):364\u2013374. https:\/\/doi.org\/10.1016\/J.TINS.2015.04.003","journal-title":"Trends Neurosci"},{"key":"4525_CR149","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS26010310","author":"C Carril Pardo","year":"2025","unstructured":"Carril Pardo C, Oyarce Merino K, Vera-Montecinos A (2025) Neuroinflammatory loop in schizophrenia, is there a relationship with symptoms or cognition decline? Int J Mol Sci. https:\/\/doi.org\/10.3390\/IJMS26010310","journal-title":"Int J Mol Sci"},{"key":"4525_CR150","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1517\/14728222.9.5.887","volume":"9","author":"JM Craft","year":"2005","unstructured":"Craft JM, Watterson DM, Van Eldik LJ (2005) Neuroinflammation: a potential therapeutic target. Expert Opin Ther Targ 9:887\u2013900. https:\/\/doi.org\/10.1517\/14728222.9.5.887","journal-title":"Expert Opin Ther Targ"},{"key":"4525_CR151","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-19-3949-5_5-1","author":"N Shebl","year":"2023","unstructured":"Shebl N (2023) Neuroinflammation and microglial activation in schizophrenia: an overview. Handb Neurodegener Disord. https:\/\/doi.org\/10.1007\/978-981-19-3949-5_5-1","journal-title":"Handb Neurodegener Disord"},{"key":"4525_CR152","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/j.euroneuro.2014.07.015","volume":"24","author":"E Plitman","year":"2014","unstructured":"Plitman E, Nakajima S, de la Fuente-Sandoval C et al (2014) Glutamate-mediated excitotoxicity in schizophrenia: a review. Eur Neuropsychopharmacol 24:1591\u20131605. https:\/\/doi.org\/10.1016\/j.euroneuro.2014.07.015","journal-title":"Eur Neuropsychopharmacol"},{"key":"4525_CR153","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1111\/BPH.13364","volume":"173","author":"LE Laskaris","year":"2016","unstructured":"Laskaris LE, Di Biase MA, Everall I et al (2016) Microglial activation and progressive brain changes in schizophrenia. Br J Pharmacol 173:666\u2013680. https:\/\/doi.org\/10.1111\/BPH.13364","journal-title":"Br J Pharmacol"},{"key":"4525_CR154","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1007\/S40263-014-0209-8","volume":"28","author":"S Glasner-Edwards","year":"2014","unstructured":"Glasner-Edwards S, Mooney LJ (2014) Methamphetamine psychosis: epidemiology and management. CNS Drugs 28:1115\u20131126. https:\/\/doi.org\/10.1007\/S40263-014-0209-8","journal-title":"CNS Drugs"},{"key":"4525_CR155","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.schres.2024.03.037","volume":"267","author":"J Cohen-Laroque","year":"2024","unstructured":"Cohen-Laroque J, Grangier I, Perez N et al (2024) Positive and negative symptoms in methamphetamine-induced psychosis compared to schizophrenia: a systematic review and meta-analysis. Schizophr Res 267:182\u2013190. https:\/\/doi.org\/10.1016\/j.schres.2024.03.037","journal-title":"Schizophr Res"},{"key":"4525_CR156","doi-asserted-by":"publisher","DOI":"10.29158\/JAAPL.240121-24","author":"B Engelson","year":"2025","unstructured":"Engelson B, Sloan L, Teravskis PJ, Gulrajani C (2025) Methamphetamine Associated Psychosis and Criminal Responsibility. J Am Acad Psychiatr Law Online. https:\/\/doi.org\/10.29158\/JAAPL.240121-24","journal-title":"J Am Acad Psychiatr Law Online"},{"key":"4525_CR157","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1038\/s41386-023-01578-4","volume":"4810","author":"S Shabani","year":"2023","unstructured":"Shabani S, Houlton S, Ghimire B et al (2023) (2023) Robust aversive effects of trace amine-associated receptor 1 activation in mice. Neuropsychopharmacol 4810:1446\u20131454. https:\/\/doi.org\/10.1038\/s41386-023-01578-4","journal-title":"Neuropsychopharmacol"},{"key":"4525_CR158","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.pneurobio.2006.07.003","volume":"79","author":"SA Burchett","year":"2006","unstructured":"Burchett SA, Hicks TP (2006) The mysterious trace amines: protean neuromodulators of synaptic transmission in mammalian brain. Prog Neurobiol 79:223\u2013246. https:\/\/doi.org\/10.1016\/j.pneurobio.2006.07.003","journal-title":"Prog Neurobiol"},{"key":"4525_CR159","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/JNC.14606","volume":"148","author":"S Dave","year":"2019","unstructured":"Dave S, Chen L, Yu C et al (2019) Methamphetamine decreases K+ channel function in human fetal astrocytes by activating the trace amine-associated receptor type-1. J Neurochem 148:29\u201345. https:\/\/doi.org\/10.1111\/JNC.14606","journal-title":"J Neurochem"},{"key":"4525_CR160","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/J.NEUBIOREV.2017.03.002","volume":"77","author":"A Bellot-Saez","year":"2017","unstructured":"Bellot-Saez A, K\u00e9kesi O, Morley JW, Buskila Y (2017) Astrocytic modulation of neuronal excitability through K + spatial buffering. Neurosci Biobehav Rev 77:87\u201397. https:\/\/doi.org\/10.1016\/J.NEUBIOREV.2017.03.002","journal-title":"Neurosci Biobehav Rev"},{"key":"4525_CR161","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/J.NEUROSCIENCE.2017.09.040","volume":"365","author":"S Ding","year":"2017","unstructured":"Ding S, Wang X, Zhuge W et al (2017) Dopamine induces glutamate accumulation in astrocytes to disrupt neuronal function leading to pathogenesis of minimal hepatic encephalopathy. Neuroscience 365:94\u2013113. https:\/\/doi.org\/10.1016\/J.NEUROSCIENCE.2017.09.040","journal-title":"Neuroscience"},{"key":"4525_CR162","doi-asserted-by":"publisher","DOI":"10.1073\/PNAS.2217396120\/SUPPL_FILE\/PNAS.2217396120.SD04.XLSX","volume":"120","author":"A Shum","year":"2023","unstructured":"Shum A, Zaichick S, McElroy GS et al (2023) Octopamine metabolically reprograms astrocytes to confer neuroprotection against \u03b1-synuclein. Proc Natl Acad Sci U S A 120:e2217396120. https:\/\/doi.org\/10.1073\/PNAS.2217396120\/SUPPL_FILE\/PNAS.2217396120.SD04.XLSX","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4525_CR163","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.biopsych.2020.12.008","volume":"90","author":"I Mantas","year":"2021","unstructured":"Mantas I, Vallianatou T, Yang Y et al (2021) TAAR1-dependent and -independent actions of tyramine in interaction with glutamate underlie central effects of monoamine oxidase inhibition. Biol Psychiatry 90:16\u201327. https:\/\/doi.org\/10.1016\/j.biopsych.2020.12.008","journal-title":"Biol Psychiatry"},{"key":"4525_CR164","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS23084453","volume":"23","author":"MH Nam","year":"2022","unstructured":"Nam MH, Sa M, Ju YH et al (2022) Revisiting the role of astrocytic MAOB in Parkinson\u2019s disease. Int J Mol Sci 23:4453. https:\/\/doi.org\/10.3390\/IJMS23084453","journal-title":"Int J Mol Sci"},{"key":"4525_CR165","doi-asserted-by":"publisher","DOI":"10.1101\/CSHPERSPECT.A020529","author":"JL Salzer","year":"2015","unstructured":"Salzer JL (2015) Schwann cell myelination. Cold Spring Harb Perspect Biol. https:\/\/doi.org\/10.1101\/CSHPERSPECT.A020529","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"4525_CR166","doi-asserted-by":"publisher","DOI":"10.3389\/FNCEL.2020.00009","volume":"14","author":"G Fattorini","year":"2020","unstructured":"Fattorini G, Melone M, Conti F (2020) A reappraisal of GAT-1 localization in neocortex. Front Cell Neurosci 14:516017. https:\/\/doi.org\/10.3389\/FNCEL.2020.00009","journal-title":"Front Cell Neurosci"},{"key":"4525_CR167","doi-asserted-by":"publisher","DOI":"10.3389\/FNCEL.2021.670346","volume":"15","author":"RM Ryan","year":"2021","unstructured":"Ryan RM, Ingram SL, Scimemi A (2021) Regulation of glutamate, GABA and dopamine transporter uptake, surface mobility and expression. Front Cell Neurosci 15:670346. https:\/\/doi.org\/10.3389\/FNCEL.2021.670346","journal-title":"Front Cell Neurosci"},{"key":"4525_CR168","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/J.COPH.2019.11.005","volume":"50","author":"D Kirdajova","year":"2020","unstructured":"Kirdajova D, Anderova M (2020) NG2 cells and their neurogenic potential. Curr Opin Pharmacol 50:53\u201360. https:\/\/doi.org\/10.1016\/J.COPH.2019.11.005","journal-title":"Curr Opin Pharmacol"},{"key":"4525_CR169","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.4103\/NRR.NRR-D-23-01031","volume":"19","author":"YR Rigo","year":"2024","unstructured":"Rigo YR, Benvenutti R, Portela LV, Strogulski NR (2024) Neurogenic potential of NG2 in neurotrauma: a systematic review. Neural Regen Res 19:2673\u20132683. https:\/\/doi.org\/10.4103\/NRR.NRR-D-23-01031","journal-title":"Neural Regen Res"},{"key":"4525_CR170","doi-asserted-by":"publisher","DOI":"10.3390\/CELLS13060474","author":"\u00c9N Soares","year":"2024","unstructured":"Soares \u00c9N, Carla A, Costa S et al (2024) Nicotinic acetylcholine receptors in glial cells as molecular target for Parkinson\u2019s disease. Cells. https:\/\/doi.org\/10.3390\/CELLS13060474","journal-title":"Cells"},{"key":"4525_CR171","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/S12974-024-03240-2","volume":"21","author":"S Xie","year":"2024","unstructured":"Xie S, Li F (2024) Ependymal cells: roles in central nervous system infections and therapeutic application. J Neuroinflammation 21:255. https:\/\/doi.org\/10.1186\/S12974-024-03240-2","journal-title":"J Neuroinflammation"},{"key":"4525_CR172","doi-asserted-by":"publisher","DOI":"10.3390\/cells11111813","author":"NV Katolikova","year":"2022","unstructured":"Katolikova NV, Vaganova AN, Efimova EV, Gainetdinov RR (2022) Expression of trace amine-associated receptors in the murine and human hippocampus based on public transcriptomic data. Cells. https:\/\/doi.org\/10.3390\/cells11111813","journal-title":"Cells"},{"key":"4525_CR173","doi-asserted-by":"publisher","DOI":"10.1093\/NAR\/GKS1193","author":"T Barrett","year":"2013","unstructured":"Barrett T, Wilhite SE, Ledoux P et al (2013) NCBI GEO: archive for functional genomics data sets\u2013update. Nucleic Acids Res. https:\/\/doi.org\/10.1093\/NAR\/GKS1193","journal-title":"Nucleic Acids Res"},{"key":"4525_CR174","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.3390\/BIOM12091259\/S1","volume":"12","author":"AN Vaganova","year":"2022","unstructured":"Vaganova AN, Katolikova NV, Murtazina RZ et al (2022) Public transcriptomic data meta-analysis demonstrates TAAR6 expression in the mental disorder-related brain areas in human and mouse brain. Biomolecules 12:1259. https:\/\/doi.org\/10.3390\/BIOM12091259\/S1","journal-title":"Biomolecules"},{"key":"4525_CR175","volume-title":"ggplot2 elegant graphics for data analysis","author":"H Wickham","year":"2016","unstructured":"Wickham H (2016) ggplot2 elegant graphics for data analysis. Springer International Publishing, Cham"},{"key":"4525_CR176","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PBIO.1002533","volume":"14","author":"R Sender","year":"2016","unstructured":"Sender R, Fuchs S, Milo R (2016) Revised estimates for the number of human and bacteria cells in the body. PLoS Biol 14:e1002533. https:\/\/doi.org\/10.1371\/JOURNAL.PBIO.1002533","journal-title":"PLoS Biol"},{"key":"4525_CR177","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/S00018-018-2943-4","volume":"76","author":"A Adak","year":"2018","unstructured":"Adak A, Khan MR (2018) An insight into gut microbiota and its functionalities. Cell Mol Life Sci C 76:473. https:\/\/doi.org\/10.1007\/S00018-018-2943-4","journal-title":"Cell Mol Life Sci C"},{"key":"4525_CR178","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/NATURE08821","volume":"464","author":"J Qin","year":"2010","unstructured":"Qin J, Li R, Raes J et al (2010) A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464:59\u201365. https:\/\/doi.org\/10.1038\/NATURE08821","journal-title":"Nature"},{"key":"4525_CR179","doi-asserted-by":"publisher","DOI":"10.1186\/S13073-016-0307-Y","author":"J Lloyd-Price","year":"2016","unstructured":"Lloyd-Price J, Abu-Ali G, Huttenhower C (2016) The healthy human microbiome. Genome Med. https:\/\/doi.org\/10.1186\/S13073-016-0307-Y","journal-title":"Genome Med"},{"key":"4525_CR180","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.annepidem.2019.09.002","volume":"39","author":"KJ Ray","year":"2019","unstructured":"Ray KJ, Cotter SY, Arzika AM et al (2019) High-throughput sequencing of pooled samples to determine community-level microbiome diversity. Ann Epidemiol 39:63\u201368. https:\/\/doi.org\/10.1016\/j.annepidem.2019.09.002","journal-title":"Ann Epidemiol"},{"key":"4525_CR181","doi-asserted-by":"publisher","DOI":"10.1126\/SCIENCE.1110591\/SUPPL_FILE\/ECKBURG_SOM.PDF","author":"PB Eckburg","year":"2005","unstructured":"Eckburg PB, Bik EM, Bernstein CN et al (2005) Microbiology: diversity of the human intestinal microbial flora. Science. https:\/\/doi.org\/10.1126\/SCIENCE.1110591\/SUPPL_FILE\/ECKBURG_SOM.PDF","journal-title":"Science"},{"key":"4525_CR182","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PBIO.0050177","volume":"5","author":"C Palmer","year":"2007","unstructured":"Palmer C, Bik EM, DiGiulio DB et al (2007) Development of the human infant intestinal microbiota. PLoS Biol 5:e177. https:\/\/doi.org\/10.1371\/JOURNAL.PBIO.0050177","journal-title":"PLoS Biol"},{"issue":"26","key":"4525_CR183","doi-asserted-by":"publisher","first-page":"11971","DOI":"10.1073\/PNAS.1002601107","volume":"107","author":"MG Dominguez-Bello","year":"2010","unstructured":"Dominguez-Bello MG, Costello EK, Contreras M et al (2010) Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A 107(26):11971\u201311975. https:\/\/doi.org\/10.1073\/PNAS.1002601107","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4525_CR184","doi-asserted-by":"publisher","DOI":"10.3402\/MEHD.V26.26050","author":"JM Rodr\u00edguez","year":"2015","unstructured":"Rodr\u00edguez JM, Murphy K, Stanton C et al (2015) The composition of the gut microbiota throughout life, with an emphasis on early life. Microb Ecol Heal Dis. https:\/\/doi.org\/10.3402\/MEHD.V26.26050","journal-title":"Microb Ecol Heal Dis"},{"key":"4525_CR185","doi-asserted-by":"publisher","first-page":"2037838","DOI":"10.1155\/2018\/2037838","volume":"2018","author":"JE Beliz\u00e1rio","year":"2018","unstructured":"Beliz\u00e1rio JE, Faintuch J, Garay-Malpartida M (2018) Gut microbiome dysbiosis and immunometabolism: new frontiers for treatment of metabolic diseases. Mediators Inflamm 2018:2037838. https:\/\/doi.org\/10.1155\/2018\/2037838","journal-title":"Mediators Inflamm"},{"key":"4525_CR186","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijerph18031189","volume":"18","author":"LR Ruzafa","year":"2021","unstructured":"Ruzafa LR, Cedillo JL, Hone AJ (2021) Nicotinic acetylcholine receptor involvement in inflammatory bowel disease and interactions with gut microbiota. Int J Environ Res Public Health 18:1\u201319. https:\/\/doi.org\/10.3390\/ijerph18031189","journal-title":"Int J Environ Res Public Health"},{"key":"4525_CR187","doi-asserted-by":"publisher","DOI":"10.3389\/FMICB.2018.01835","volume":"9","author":"ZY Kho","year":"2018","unstructured":"Kho ZY, Lal SK (2018) The human gut microbiome - a potential controller of wellness and disease. Front Microbiol 9:356589. https:\/\/doi.org\/10.3389\/FMICB.2018.01835","journal-title":"Front Microbiol"},{"key":"4525_CR188","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-024-01743-1","volume":"91","author":"JS Loh","year":"2024","unstructured":"Loh JS, Mak WQ, Tan LKS et al (2024) (2024) Microbiota\u2013gut\u2013brain axis and its therapeutic applications in neurodegenerative diseases. Signal Transduct Target Ther 91:1\u201353. https:\/\/doi.org\/10.1038\/s41392-024-01743-1","journal-title":"Signal Transduct Target Ther"},{"key":"4525_CR189","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/J.SCHRES.2013.05.018","volume":"148","author":"EG Severance","year":"2013","unstructured":"Severance EG, Gressitt KL, Stallings CR et al (2013) Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia. Schizophr Res 148:130\u2013137. https:\/\/doi.org\/10.1016\/J.SCHRES.2013.05.018","journal-title":"Schizophr Res"},{"key":"4525_CR190","doi-asserted-by":"publisher","first-page":"7056","DOI":"10.1007\/S12035-019-1578-2","volume":"56","author":"M Maes","year":"2019","unstructured":"Maes M, Sirivichayakul S, Kanchanatawan B, Vodjani A (2019) Upregulation of the intestinal paracellular pathway with breakdown of tight and adherens junctions in deficit schizophrenia. Mol Neurobiol 56:7056\u20137073. https:\/\/doi.org\/10.1007\/S12035-019-1578-2","journal-title":"Mol Neurobiol"},{"key":"4525_CR191","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e34092","author":"S Ashique","year":"2024","unstructured":"Ashique S, Mohanto S, Ahmed MG et al (2024) Gut-brain axis: a cutting-edge approach to target neurological disorders and potential synbiotic application. Heliyon. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34092","journal-title":"Heliyon"},{"issue":"1","key":"4525_CR192","doi-asserted-by":"publisher","DOI":"10.1038\/S41598-025-86858-3","volume":"15","author":"C Doenyas","year":"2025","unstructured":"Doenyas C, Clarke G, Cserj\u00e9si R (2025) Gut-brain axis and neuropsychiatric health: recent advances. Sci Rep 15(1):3415. https:\/\/doi.org\/10.1038\/S41598-025-86858-3","journal-title":"Sci Rep"},{"key":"4525_CR193","doi-asserted-by":"publisher","DOI":"10.3389\/FNINS.2025.1592604","author":"RM Voigt","year":"2025","unstructured":"Voigt RM, Lowry CA (2025) Editorial: The microbiome-gut-brain axis and posttraumatic stress disorder. Front Neurosci. https:\/\/doi.org\/10.3389\/FNINS.2025.1592604","journal-title":"Front Neurosci"},{"key":"4525_CR194","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-022-34667-x","volume":"131","author":"ZD Wallen","year":"2022","unstructured":"Wallen ZD, Demirkan A, Twa G et al (2022) (2022) Metagenomics of Parkinson\u2019s disease implicates the gut microbiome in multiple disease mechanisms. Nat Commun 131:1\u201320. https:\/\/doi.org\/10.1038\/s41467-022-34667-x","journal-title":"Nat Commun"},{"key":"4525_CR195","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.14336\/AD.2022.01281","volume":"13","author":"H Yang","year":"2022","unstructured":"Yang H, Li S, Le W (2022) Intestinal permeability, dysbiosis, inflammation and enteric glia cells: the intestinal etiology of Parkinson\u2019s disease. Aging Dis 13:1381. https:\/\/doi.org\/10.14336\/AD.2022.01281","journal-title":"Aging Dis"},{"key":"4525_CR196","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2021.767456","volume":"12","author":"LW Kaminsky","year":"2021","unstructured":"Kaminsky LW, Al-Sadi R, Ma TY (2021) IL-1\u03b2 and the intestinal epithelial tight junction barrier. Front Immunol 12:767456. https:\/\/doi.org\/10.3389\/FIMMU.2021.767456","journal-title":"Front Immunol"},{"key":"4525_CR197","doi-asserted-by":"publisher","DOI":"10.3389\/FNINS.2022.820106","volume":"16","author":"X Li","year":"2022","unstructured":"Li X, Chen LM, Kumar G et al (2022) Therapeutic interventions of gut-brain axis as novel strategies for treatment of alcohol use disorder associated cognitive and mood dysfunction. Front Neurosci 16:820106. https:\/\/doi.org\/10.3389\/FNINS.2022.820106","journal-title":"Front Neurosci"},{"key":"4525_CR198","doi-asserted-by":"publisher","DOI":"10.3389\/FGENE.2019.00098","volume":"10","author":"TT Huang","year":"2019","unstructured":"Huang TT, Lai JB, Du YL et al (2019) Current understanding of gut microbiota in mood disorders: an update of human studies. Front Genet 10:435190. https:\/\/doi.org\/10.3389\/FGENE.2019.00098","journal-title":"Front Genet"},{"issue":"22","key":"4525_CR199","doi-asserted-by":"publisher","first-page":"7671","DOI":"10.3390\/IJMS22147671","volume":"7671","author":"N Munawar","year":"2021","unstructured":"Munawar N, Ahsan K, Muhammad K et al (2021) Hidden role of gut microbiome dysbiosis in schizophrenia: antipsychotics or psychobiotics as therapeutics? Int J Mol Sci 2021, Vol 22. Page 7671(22):7671. https:\/\/doi.org\/10.3390\/IJMS22147671","journal-title":"Page"},{"key":"4525_CR200","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/J.SCHRES.2020.02.012","volume":"234","author":"A Minichino","year":"2021","unstructured":"Minichino A, Brondino N, Solmi M et al (2021) The gut-microbiome as a target for the treatment of schizophrenia: a systematic review and meta-analysis of randomised controlled trials of add-on strategies. Schizophr Res 234:58\u201370. https:\/\/doi.org\/10.1016\/J.SCHRES.2020.02.012","journal-title":"Schizophr Res"},{"key":"4525_CR201","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/J.CONB.2019.12.003","volume":"62","author":"LM Frankiensztajn","year":"2020","unstructured":"Frankiensztajn LM, Elliott E, Koren O (2020) The microbiota and the hypothalamus-pituitary-adrenocortical (HPA) axis, implications for anxiety and stress disorders. Curr Opin Neurobiol 62:76\u201382. https:\/\/doi.org\/10.1016\/J.CONB.2019.12.003","journal-title":"Curr Opin Neurobiol"},{"key":"4525_CR202","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1002\/DA.22936;PAGE:STRING:ARTICLE\/CHAPTER","volume":"36","author":"M Van Ameringen","year":"2019","unstructured":"Van Ameringen M, Turna J, Patterson B et al (2019) The gut microbiome in psychiatry: a primer for clinicians. Depress Anxiety 36:1004\u20131025. https:\/\/doi.org\/10.1002\/DA.22936;PAGE:STRING:ARTICLE\/CHAPTER","journal-title":"Depress Anxiety"},{"key":"4525_CR203","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/J.NEUBIOREV.2019.12.011","volume":"108","author":"B Golofast","year":"2020","unstructured":"Golofast B, Vales K (2020) The connection between microbiome and schizophrenia. Neurosci Biobehav Rev 108:712\u2013731. https:\/\/doi.org\/10.1016\/J.NEUBIOREV.2019.12.011","journal-title":"Neurosci Biobehav Rev"},{"key":"4525_CR204","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/J.SCHRES.2020.02.010","volume":"234","author":"JR Kelly","year":"2021","unstructured":"Kelly JR, Minuto C, Cryan JF et al (2021) The role of the gut microbiome in the development of schizophrenia. Schizophr Res 234:4\u201323. https:\/\/doi.org\/10.1016\/J.SCHRES.2020.02.010","journal-title":"Schizophr Res"},{"key":"4525_CR205","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1080\/07853890.2020.1808239","volume":"52","author":"T Halverson","year":"2020","unstructured":"Halverson T, Alagiakrishnan K (2020) Gut microbes in neurocognitive and mental health disorders. Ann Med 52:423. https:\/\/doi.org\/10.1080\/07853890.2020.1808239","journal-title":"Ann Med"},{"key":"4525_CR206","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/J.SCHRES.2018.01.002","volume":"197","author":"Y Shen","year":"2018","unstructured":"Shen Y, Xu J, Li Z et al (2018) Analysis of gut microbiota diversity and auxiliary diagnosis as a biomarker in patients with schizophrenia: a cross-sectional study. Schizophr Res 197:470\u2013477. https:\/\/doi.org\/10.1016\/J.SCHRES.2018.01.002","journal-title":"Schizophr Res"},{"key":"4525_CR207","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/J.SCHRES.2017.04.017","volume":"192","author":"E Schwarz","year":"2018","unstructured":"Schwarz E, Maukonen J, Hyyti\u00e4inen T et al (2018) Analysis of microbiota in first episode psychosis identifies preliminary associations with symptom severity and treatment response. Schizophr Res 192:398\u2013403. https:\/\/doi.org\/10.1016\/J.SCHRES.2017.04.017","journal-title":"Schizophr Res"},{"key":"4525_CR208","doi-asserted-by":"publisher","DOI":"10.1126\/SCIADV.AAU8317","author":"P Zheng","year":"2019","unstructured":"Zheng P, Zeng B, Liu M et al (2019) The gut microbiome from patients with schizophrenia modulates the glutamate-glutamine-GABA cycle and schizophrenia-relevant behaviors in mice. Sci Adv. https:\/\/doi.org\/10.1126\/SCIADV.AAU8317","journal-title":"Sci Adv"},{"key":"4525_CR209","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/J.JPSYCHIRES.2018.01.013","volume":"99","author":"TT Nguyen","year":"2018","unstructured":"Nguyen TT, Kosciolek T, Eyler LT et al (2018) Overview and systematic review of studies of microbiome in schizophrenia and bipolar disorder. J Psychiatr Res 99:50\u201361. https:\/\/doi.org\/10.1016\/J.JPSYCHIRES.2018.01.013","journal-title":"J Psychiatr Res"},{"key":"4525_CR210","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.bbi.2022.02.007","volume":"102","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Fan Q, Hou Y et al (2022) Bacteroides species differentially modulate depression-like behavior via gut-brain metabolic signaling. Brain Behav Immun 102:11\u201322. https:\/\/doi.org\/10.1016\/j.bbi.2022.02.007","journal-title":"Brain Behav Immun"},{"key":"4525_CR211","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104527","author":"L Liu","year":"2023","unstructured":"Liu L, Wang H, Chen X et al (2023) Gut microbiota and its metabolites in depression: from pathogenesis to treatment. EBioMedicine. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104527","journal-title":"EBioMedicine"},{"key":"4525_CR212","doi-asserted-by":"publisher","DOI":"10.3390\/MEDSCI6020029","author":"I Argou-Cardozo","year":"2018","unstructured":"Argou-Cardozo I, Zeid\u00e1n-Chuli\u00e1 F (2018) Clostridium bacteria and autism spectrum conditions: a systematic review and hypothetical contribution of environmental glyphosate levels. Med Sci. https:\/\/doi.org\/10.3390\/MEDSCI6020029","journal-title":"Med Sci"},{"key":"4525_CR213","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/PHAR.1890","volume":"37","author":"SA Flowers","year":"2017","unstructured":"Flowers SA, Evans SJ, Ward KM et al (2017) Interaction between atypical antipsychotics and the gut microbiome in a bipolar disease cohort. Pharmacother J Hum Pharmacol Drug Ther 37:261\u2013267. https:\/\/doi.org\/10.1002\/PHAR.1890","journal-title":"Pharmacother J Hum Pharmacol Drug Ther"},{"key":"4525_CR214","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/J.SCHRES.2018.05.017","volume":"201","author":"X Yuan","year":"2018","unstructured":"Yuan X, Zhang P, Wang Y et al (2018) Changes in metabolism and microbiota after 24-week risperidone treatment in drug na\u00efve, normal weight patients with first episode schizophrenia. Schizophr Res 201:299\u2013306. https:\/\/doi.org\/10.1016\/J.SCHRES.2018.05.017","journal-title":"Schizophr Res"},{"key":"4525_CR215","doi-asserted-by":"publisher","DOI":"10.3389\/FPSYT.2019.00093","volume":"10","author":"CH Lin","year":"2019","unstructured":"Lin CH, Lane HY (2019) Early identification and intervention of schizophrenia: insight from hypotheses of glutamate dysfunction and oxidative stress. Front Psychiatry 10:441787. https:\/\/doi.org\/10.3389\/FPSYT.2019.00093","journal-title":"Front Psychiatry"},{"key":"4525_CR216","doi-asserted-by":"publisher","DOI":"10.3389\/FMICB.2015.00567","author":"AX Van der Stel","year":"2015","unstructured":"Van der Stel AX, Van Mourik A, \u0141aniewski P et al (2015) The campylobacter jejuni RacRS two-component system activates the glutamate synthesis by directly upregulating \u03b3-glutamyltranspeptidase (GGT). Front Microbiol. https:\/\/doi.org\/10.3389\/FMICB.2015.00567","journal-title":"Front Microbiol"},{"key":"4525_CR217","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS21082676","author":"CH Chang","year":"2020","unstructured":"Chang CH, Lin CH, Lane HY (2020) D-glutamate and Gut microbiota in Alzheimer\u2019s disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/IJMS21082676","journal-title":"Int J Mol Sci"},{"key":"4525_CR218","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-019-0475-4","author":"F Zhu","year":"2019","unstructured":"Zhu F, Guo R, Wang W et al (2019) Transplantation of microbiota from drug-free patients with schizophrenia causes schizophrenia-like abnormal behaviors and dysregulated kynurenine metabolism in mice. Mol Psychiatry. https:\/\/doi.org\/10.1038\/s41380-019-0475-4","journal-title":"Mol Psychiatry"},{"key":"4525_CR219","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2012.77","author":"G Clarke","year":"2012","unstructured":"Clarke G, Grenham S, Scully P et al (2012) The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol Psychiatry. https:\/\/doi.org\/10.1038\/mp.2012.77","journal-title":"Mol Psychiatry"},{"key":"4525_CR220","doi-asserted-by":"publisher","DOI":"10.18502\/IJM.V15I1.11912","author":"M Navidinia","year":"2023","unstructured":"Navidinia M, Goudarzi M, Seyfi E (2023) The clinical outcomes of gut-brain axis (GBA) microbiota influence on psychiatric disorders. Iran J Microbiol. https:\/\/doi.org\/10.18502\/IJM.V15I1.11912","journal-title":"Iran J Microbiol"},{"key":"4525_CR221","doi-asserted-by":"publisher","DOI":"10.1073\/PNAS.151105198","author":"B Borowsky","year":"2001","unstructured":"Borowsky B, Adham N, Jones KA et al (2001) Trace amines: Identification of a family of mammalian G protein-coupled receptors. Proc Natl Acad Sci U S A. https:\/\/doi.org\/10.1073\/PNAS.151105198","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4525_CR222","doi-asserted-by":"publisher","DOI":"10.1080\/16512235.2017.1353881","author":"B Pugin","year":"2017","unstructured":"Pugin B, Barcik W, Westermann P et al (2017) A wide diversity of bacteria from the human gut produces and degrades biogenic amines. Microb Ecol Health Dis. https:\/\/doi.org\/10.1080\/16512235.2017.1353881","journal-title":"Microb Ecol Health Dis"},{"key":"4525_CR223","doi-asserted-by":"publisher","DOI":"10.3389\/FPSYT.2024.1484925\/PDF","author":"IS Zhukov","year":"2024","unstructured":"Zhukov IS, Alnefeesi Y, Krotova NA et al (2024) Trace amine-associated receptor 1 agonist reduces aggression in brain serotonin-deficient tryptophan hydroxylase 2 knockout rats. Front Psychiatry. https:\/\/doi.org\/10.3389\/FPSYT.2024.1484925\/PDF","journal-title":"Front Psychiatry"},{"key":"4525_CR224","doi-asserted-by":"publisher","DOI":"10.1124\/JPET.106.116863","author":"Z Xie","year":"2007","unstructured":"Xie Z, Westmoreland SV, Bahn ME et al (2007) Rhesus monkey trace amine-associated receptor 1 signaling: enhancement by monoamine transporters and attenuation by the D2 autoreceptor in vitro. J Pharmacol Exp Ther. https:\/\/doi.org\/10.1124\/JPET.106.116863","journal-title":"J Pharmacol Exp Ther"},{"key":"4525_CR225","doi-asserted-by":"publisher","DOI":"10.1016\/j.meatsci.2013.06.030","author":"T Lynnes","year":"2014","unstructured":"Lynnes T, Horne SM, Pr\u00fc\u00df BM (2014) \u00df-phenylethylamine as a novel nutrient treatment to reduce bacterial contamination due to Escherichia coli O157: H7 on beef meat. Meat Sci. https:\/\/doi.org\/10.1016\/j.meatsci.2013.06.030","journal-title":"Meat Sci"},{"key":"4525_CR226","doi-asserted-by":"publisher","DOI":"10.1017\/S0007114508123431","author":"KJ Broadley","year":"2009","unstructured":"Broadley KJ, Akhtar Anwar M, Herbert AA et al (2009) Effects of dietary amines on the gut and its vasculature. Br J nutr. https:\/\/doi.org\/10.1017\/S0007114508123431","journal-title":"Br J nutr"},{"key":"4525_CR227","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.cell.2015.02.047","volume":"161","author":"JM Yano","year":"2015","unstructured":"Yano JM, Yu K, Donaldson GP et al (2015) Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell 161:264\u2013276. https:\/\/doi.org\/10.1016\/j.cell.2015.02.047","journal-title":"Cell"},{"key":"4525_CR228","doi-asserted-by":"publisher","DOI":"10.1080\/10408398.2010.500545","author":"A Marcobal","year":"2012","unstructured":"Marcobal A, de las Rivas B, Landete JM et al (2012) Tyramine and phenylethylamine biosynthesis by food bacteria. Crit Rev Food Sci Nutr. https:\/\/doi.org\/10.1080\/10408398.2010.500545","journal-title":"Crit Rev Food Sci Nutr"},{"key":"4525_CR229","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2025.107810","author":"S Ruan","year":"2025","unstructured":"Ruan S, Li Y, Ning Z et al (2025) Gut microbe-derived aromatic trace amines mediate individual variability in response to herbal medicine CDD-2101 for functional constipation. Pharmacol Res. https:\/\/doi.org\/10.1016\/j.phrs.2025.107810","journal-title":"Pharmacol Res"},{"key":"4525_CR230","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2017.07.002","author":"MD Berry","year":"2017","unstructured":"Berry MD, Gainetdinov RR, Hoener MC, Shahid M (2017) Pharmacology of human trace amine-associated receptors: therapeutic opportunities and challenges. Pharmacol Ther. https:\/\/doi.org\/10.1016\/j.pharmthera.2017.07.002","journal-title":"Pharmacol Ther"},{"key":"4525_CR231","doi-asserted-by":"publisher","DOI":"10.1152\/AJPGI.00056.2008","author":"M Kidd","year":"2008","unstructured":"Kidd M, Modlin IM, Gustafsson BI et al (2008) Luminal regulation of normal and neoplastic human EC cell serotonin release is mediated by bile salts, amines, tastants, and olfactants. Am J Physiol-Gastrointest Liver Physiol. https:\/\/doi.org\/10.1152\/AJPGI.00056.2008","journal-title":"Am J Physiol-Gastrointest Liver Physiol"},{"key":"4525_CR232","doi-asserted-by":"publisher","DOI":"10.1189\/JLB.0912433","author":"A Babusyte","year":"2013","unstructured":"Babusyte A, Kotthoff M, Fiedler J, Krautwurst D (2013) Biogenic amines activate blood leukocytes via trace amine-associated receptors TAAR1 and TAAR2. J Leukoc Biol. https:\/\/doi.org\/10.1189\/JLB.0912433","journal-title":"J Leukoc Biol"},{"key":"4525_CR233","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2015.09.015","author":"S Raab","year":"2016","unstructured":"Raab S, Wang H, Uhles S et al (2016) Incretin-like effects of small molecule trace amine-associated receptor 1 agonists. Mol Metab. https:\/\/doi.org\/10.1016\/j.molmet.2015.09.015","journal-title":"Mol Metab"},{"key":"4525_CR234","doi-asserted-by":"publisher","DOI":"10.1189\/JLB.4A0814-395RR","author":"U Sriram","year":"2016","unstructured":"Sriram U, Cenna JM, Haldar B et al (2016) Methamphetamine induces trace amine-associated receptor 1 (TAAR1) expression in human T lymphocytes: role in immunomodulation. J Leukoc Biol. https:\/\/doi.org\/10.1189\/JLB.4A0814-395RR","journal-title":"J Leukoc Biol"},{"key":"4525_CR235","doi-asserted-by":"publisher","DOI":"10.1080\/09168451.2016.1274640","author":"H Ohta","year":"2017","unstructured":"Ohta H, Takebe Y, Murakami Y et al (2017) Tyramine and \u03b2-phenylethylamine, from fermented food products, as agonists for the human trace amine-associated receptor 1 (hTAAR1) in the stomach. Biosci Biotechnol Biochem. https:\/\/doi.org\/10.1080\/09168451.2016.1274640","journal-title":"Biosci Biotechnol Biochem"},{"key":"4525_CR236","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/NPR2.12227","volume":"42","author":"I Ishida","year":"2022","unstructured":"Ishida I, Ogura J, Aizawa E et al (2022) Gut permeability and its clinical relevance in schizophrenia. Neuropsychopharmacol Rep 42:70\u201376. https:\/\/doi.org\/10.1002\/NPR2.12227","journal-title":"Neuropsychopharmacol Rep"},{"key":"4525_CR237","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1126\/SCIENCE.504988","volume":"206","author":"SG Potkin","year":"1979","unstructured":"Potkin SG, Karoum F, Chuang LW et al (1979) Phenylethylamine in paranoid chronic schizophrenia. Science 206:470\u2013471. https:\/\/doi.org\/10.1126\/SCIENCE.504988","journal-title":"Science"},{"key":"4525_CR238","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(91)90168-L","author":"R O\u2019Reilly","year":"1991","unstructured":"O\u2019Reilly R, Davis BA, Durden DA et al (1991) Plasma phenylethylamine in schizophrenic patients. Biol Psychiatry. https:\/\/doi.org\/10.1016\/0006-3223(91)90168-L","journal-title":"Biol Psychiatry"},{"key":"4525_CR239","doi-asserted-by":"publisher","DOI":"10.1177\/070674379504000417","author":"S Shirkande","year":"1995","unstructured":"Shirkande S, O\u2019Reilly R, Davis B et al (1995) Plasma phenylethylamine levels of schizophrenic patients. Can J Psychiatry. https:\/\/doi.org\/10.1177\/070674379504000417","journal-title":"Can J Psychiatry"},{"key":"4525_CR240","doi-asserted-by":"publisher","DOI":"10.3390\/BIOMEDICINES12040893","author":"VI Moiseenko","year":"2024","unstructured":"Moiseenko VI, Apryatina VA, Gainetdinov RR, Apryatin SA (2024) Trace amine-associated receptors\u2019 role in immune system functions. Biomedicines. https:\/\/doi.org\/10.3390\/BIOMEDICINES12040893","journal-title":"Biomedicines"},{"key":"4525_CR241","doi-asserted-by":"publisher","DOI":"10.1159\/000534185","author":"EG Severance","year":"2023","unstructured":"Severance EG, Prandovszky E, Yang S et al (2023) Prospects and pitfalls of plasma complement C4 in schizophrenia: building a better biomarker. Dev Neurosci. https:\/\/doi.org\/10.1159\/000534185","journal-title":"Dev Neurosci"},{"key":"4525_CR242","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2016.11.019","author":"EG Severance","year":"2017","unstructured":"Severance EG, Gressitt KL, Stallings CR et al (2017) Probiotic normalization of Candida albicans in schizophrenia: a randomized, placebo-controlled, longitudinal pilot study. Brain Behav Immun. https:\/\/doi.org\/10.1016\/j.bbi.2016.11.019","journal-title":"Brain Behav Immun"},{"key":"4525_CR243","doi-asserted-by":"publisher","DOI":"10.1038\/S41598-017-10034-5","author":"ML Santoru","year":"2017","unstructured":"Santoru ML, Piras C, Murgia A et al (2017) Cross sectional evaluation of the gut-microbiome metabolome axis in an Italian cohort of IBD patients. Sci Rep. https:\/\/doi.org\/10.1038\/S41598-017-10034-5","journal-title":"Sci Rep"},{"key":"4525_CR244","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2015.08.011","author":"A Harmeier","year":"2015","unstructured":"Harmeier A, Obermueller S, Meyer CA et al (2015) Trace amine-associated receptor 1 activation silences GSK3\u03b2 signaling of TAAR1 and D2R heteromers. Eur Neuropsychopharmacol. https:\/\/doi.org\/10.1016\/j.euroneuro.2015.08.011","journal-title":"Eur Neuropsychopharmacol"},{"key":"4525_CR245","doi-asserted-by":"publisher","DOI":"10.3389\/FPHAR.2018.00680","author":"SL Christian","year":"2018","unstructured":"Christian SL, Berry MD (2018) Trace amine-associated receptors as novel therapeutic targets for immunomodulatory disorders. Front Pharmacol. https:\/\/doi.org\/10.3389\/FPHAR.2018.00680","journal-title":"Front Pharmacol"},{"key":"4525_CR246","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2015.11.014","author":"DK Grandy","year":"2016","unstructured":"Grandy DK, Miller GM, Li JX (2016) \u201cTAARgeting addiction\u201d-the alamo bears witness to another revolution. an overview of the plenary symposium of the 2015 behavior, biology and chemistry conference. Drug Alcohol Depend. https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.11.014","journal-title":"Drug Alcohol Depend"},{"key":"4525_CR247","doi-asserted-by":"publisher","DOI":"10.3390\/NU13062099","author":"Y Chen","year":"2021","unstructured":"Chen Y, Xu J, Chen Y (2021) Regulation of neurotransmitters by the gut microbiota and effects on cognition in neurological disorders. Nutrients. https:\/\/doi.org\/10.3390\/NU13062099","journal-title":"Nutrients"},{"key":"4525_CR248","doi-asserted-by":"publisher","DOI":"10.1111\/NYAS.14993","author":"JB Lynch","year":"2023","unstructured":"Lynch JB, Hsiao EY (2023) Toward understanding links between the microbiome and neurotransmitters. Ann N Y Acad Sci. https:\/\/doi.org\/10.1111\/NYAS.14993","journal-title":"Ann N Y Acad Sci"},{"key":"4525_CR249","doi-asserted-by":"publisher","DOI":"10.3389\/FMICB.2023.1098412","author":"S Miri","year":"2023","unstructured":"Miri S, Yeo JD, Abubaker S, Hammami R (2023) Neuromicrobiology, an emerging neurometabolic facet of the gut microbiome? Front Microbiol. https:\/\/doi.org\/10.3389\/FMICB.2023.1098412","journal-title":"Front Microbiol"},{"key":"4525_CR250","doi-asserted-by":"publisher","DOI":"10.1111\/J.1471-4159.2010.07109.X","author":"GM Miller","year":"2011","unstructured":"Miller GM (2011) The emerging role of trace amine associated receptor 1 in the functional regulation of monoamine transporters and dopaminergic activity. J Neurochem. https:\/\/doi.org\/10.1111\/J.1471-4159.2010.07109.X","journal-title":"J Neurochem"},{"key":"4525_CR251","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4614-6438-9_101881-1","author":"VM Lam","year":"2017","unstructured":"Lam VM, Gainetdinov RR, Salahpour A, Espinoza S (2017) Trace amine-associated receptor 1 (TAAR1). Encycl Signal Mol. https:\/\/doi.org\/10.1007\/978-1-4614-6438-9_101881-1","journal-title":"Encycl Signal Mol"},{"key":"4525_CR252","doi-asserted-by":"publisher","DOI":"10.1038\/S41380-022-01739-9","author":"D Grinchii","year":"2022","unstructured":"Grinchii D, Hoener MC, Khoury T et al (2022) Effects of acute and chronic administration of trace amine-associated receptor 1 (TAAR1) ligands on in vivo excitability of central monoamine-secreting neurons in rats. Mol Psychiatry. https:\/\/doi.org\/10.1038\/S41380-022-01739-9","journal-title":"Mol Psychiatry"},{"key":"4525_CR253","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/J.JNEUROIM.2007.08.006","volume":"192","author":"DA Nelson","year":"2007","unstructured":"Nelson DA, Tolbert MD, Singh SJ, Bost KL (2007) Expression of neuronal trace amine-associated receptor (Taar) mRNAs in leukocytes. J Neuroimmunol 192:21\u201330. https:\/\/doi.org\/10.1016\/J.JNEUROIM.2007.08.006","journal-title":"J Neuroimmunol"},{"key":"4525_CR254","doi-asserted-by":"publisher","DOI":"10.1124\/JPET.107.132647","author":"L Lindemann","year":"2008","unstructured":"Lindemann L, Meyer CA, Jeanneau K et al (2008) Trace amine-associated receptor 1 modulates dopaminergic activity. J Pharmacol Exp Ther. https:\/\/doi.org\/10.1124\/JPET.107.132647","journal-title":"J Pharmacol Exp Ther"},{"key":"4525_CR255","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS22168907","author":"I Mantas","year":"2021","unstructured":"Mantas I, Millan MJ, Di Cara B et al (2021) Trace amine-associated receptor 1 contributes to diverse functional actions of o-phenyl-iodotyramine in mice but not to the effects of monoamine-based antidepressants. Int J Mol Sci. https:\/\/doi.org\/10.3390\/IJMS22168907","journal-title":"Int J Mol Sci"},{"key":"4525_CR256","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA118.005464","author":"ES Michael","year":"2019","unstructured":"Michael ES, Covic L, Kuliopulos A (2019) Trace amine\u2013associated receptor 1 (TAAR1) promotes anti-diabetic signaling in insulin-secreting cells. J Biol Chem. https:\/\/doi.org\/10.1074\/jbc.RA118.005464","journal-title":"J Biol Chem"},{"key":"4525_CR257","doi-asserted-by":"publisher","DOI":"10.1001\/JAMAPSYCHIATRY.2021.0015","author":"K Hagi","year":"2021","unstructured":"Hagi K, Nosaka T, Dickinson D et al (2021) Association between cardiovascular risk factors and cognitive impairment in people with schizophrenia: a systematic review and meta-analysis. JAMA Psychiatr. https:\/\/doi.org\/10.1001\/JAMAPSYCHIATRY.2021.0015","journal-title":"JAMA Psychiatr"},{"key":"4525_CR258","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291716001902","author":"DC Chen","year":"2016","unstructured":"Chen DC, Du XD, Yin GZ et al (2016) Impaired glucose tolerance in first-episode drug-na\u00efve patients with schizophrenia: relationships with clinical phenotypes and cognitive deficits. Psychol Med. https:\/\/doi.org\/10.1017\/S0033291716001902","journal-title":"Psychol Med"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-025-04525-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-025-04525-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-025-04525-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:09:49Z","timestamp":1761847789000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-025-04525-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,21]]},"references-count":258,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["4525"],"URL":"https:\/\/doi.org\/10.1007\/s11064-025-04525-5","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,21]]},"assertion":[{"value":"22 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"273"}}